ÏÖ´ú·Ö×ÓÉúÎïѧ±Ê¼Ç£¨ÖìÓñÏͰ棩 o,|[GhtHqs
µÚÒ»½² ÐòÂÛ sc,Xw:YO
^Q+g({
¶þ¡¢ÏÖ´ú·Ö×ÓÉúÎïѧÖеÄÖ÷ÒªÀï³Ì±® L:@7tc.
·Ö×ÓÉúÎïѧÊÇÑо¿ºËËá¡¢µ°°×ÖʵÈËùÓÐÉúÎï´ó·Ö×ÓµÄÐÎ̬¡¢½á¹¹ÌØÕ÷¼°ÆäÖØÒªÐÔ¡¢¹æÂÉÐÔºÍÏ໥¹ØÏµµÄ¿ÆÑ§£¬ÊÇÈËÀà´Ó·Ö×ÓˮƽÉÏÕæÕý½Ò¿ªÉúÎïÊÀ½çµÄ°ÂÃØ£¬Óɱ»¶¯µØÊÊÓ¦×ÔÈ»½çתÏòÖ÷¶¯µØ¸ÄÔìºÍÖØ×é×ÔÈ»½çµÄ»ù´¡Ñ§¿Æ¡£µ±ÈËÃÇÒâʶµ½Í¬Ò»ÉúÎﲻͬÊÀ´úÖ®¼äµÄÁ¬ÐøÐÔÊÇÓÉÉúÎïÌå×ÔÉíËùЯ´øµÄÒÅ´«ÎïÖÊËù¾ö¶¨µÄ£¬¿ÆÑ§¼ÒΪ½ÒʾÕâЩÒÅ´«ÃÜÂëËù½øÐеÄŬÁ¦¾Í³ÉΪÈËÀàÕ÷·þ×ÔÈ»µÄÒ»²¿·Ö£¬¶øÒÔÉúÎï´ó·Ö×ÓΪÑо¿¶ÔÏñµÄ·Ö×ÓÉúÎïѧ¾ÍѸËÙ³ÉΪÏÖ´úÉç»áÖÐ×î¾ß»îÁ¦µÄ¿ÆÑ§¡£ ,}K<*t[I
´Ó1847ÄêSchleidenºÍSchwannÌá³ö"ϸ°ûѧ˵"£¬Ö¤Ã÷¶¯¡¢Ö²Îï¶¼ÊÇÓÉϸ°û×é³ÉµÄµ½½ñÌ죬ËäÈ»²»¹ý¶Ì¶ÌÒ»°Ù¶àÄêʱ¼ä£¬ÎÒÃǶÔÉúÎï´ó·Ö×Ó--ϸ°ûµÄ»¯Ñ§×é³ÉÈ´ÓÐÁËÉî¿ÌµÄÈÏʶ¡£Ãϵ¶ûµÄÒÅ´«Ñ§¹æÂÉ×îÏÈʹÈËÃǶÔÐÔ×´ÒÅ´«²úÉúÁËÀíÐÔÈÏʶ£¬¶øMorganµÄ»ùÒòѧ˵Ôò½øÒ»²½½«"ÐÔ×´"Óë"»ùÒò"ÏàñîÁª£¬³ÉΪ·Ö×ÓÒÅ´«Ñ§µÄµì»ùʯ¡£WatsonºÍCrickËùÌá³öµÄÍÑÑõºËÌÇËáË«ÂÝÐýÄ£ÐÍ£¬Îª³ä·Ö½ÒʾÒÅ´«ÐÅÏ¢µÄ´«µÝ¹æÂÉÆÌÆ½Á˵À·¡£ÔÚµ°°×ÖÊ»¯Ñ§·½Ã棬¼ÌSumnerÔÚ1936Äê֤ʵøÊǵ°°×ÖÊÖ®ºó£¬SangerÀûÓÃÖ½µçÓ¾¼°²ãÎö¼¼ÊõÓÚ1953ÄêÊ״βûÃ÷ÒȵºËصÄÒ»¼¶½á¹¹£¬¿ª´´Á˵°°×ÖÊÐòÁзÖÎöµÄÏȺӡ£¶øKendrewºÍPerutzÀûÓÃXÉäÏßÑÜÉä¼¼Êõ½âÎöÁ˼¡ºìµ°°×£¨myoglobin£©¼°Ñªºìµ°°×£¨hemoglobin£©µÄÈýά½á¹¹£¬ÂÛÖ¤ÁËÕâЩµ°°×ÖÊÔÚÊäËÍ·Ö×ÓÑõ¹ý³ÌÖеÄÌØÊâ×÷Ó㬳ÉΪÑо¿ÉúÎï´ó·Ö×Ó¿Õ¼äÁ¢Ìå¹¹Ð͵ÄÏÈÇý¡£ As>_J=8} 3
1910Ä꣬µÂ¹ú¿ÆÑ§¼ÒKosselµÚÒ»¸ö·ÖÀëÁËÏÙàÑßÊ£¬ÐØÏÙà×ऺÍ×é°±Ëá¡£ E*+{t~
1959Ä꣬ÃÀ¹ú¿ÆÑ§¼ÒUchoaµÚÒ»´ÎºÏ³ÉÁ˺ËÌǺËËᣬʵÏÖÁ˽«»ùÒòÄÚµÄÒÅ´«ÐÅϢͨ¹ýRNA·Òë³Éµ°°×ÖʵĹý³Ì¡£Í¬Ä꣬KornbergʵÏÖÁËÊÔ¹ÜÄÚϸ¾úϸ°ûÖÐDNAµÄ¸´ÖÆ¡£ eq
UME
1962Ä꣬Watson£¨ÃÀ£©ºÍCrick£¨Ó¢£©ÒòΪÔÚ1953ÄêÌá³öDNAµÄ·´ÏòƽÐÐË«ÂÝÐýÄ£ÐͶøÓëWilkins¹²»ñNobleÉúÀíҽѧ½±£¬ºóÕßͨ¹ýXÉäÏßÑÜÉä֤ʵÁËWatson-CrickÄ£ÐÍ¡£ 6?w0
1965Ä꣬·¨¹ú¿ÆÑ§¼ÒJacobºÍMonodÌá³ö²¢Ö¤ÊµÁ˲Ù×Ý×Ó£¨operon£©×÷Ϊµ÷½Úϸ¾úϸ°û´úлµÄ·Ö×Ó»úÖÆ¡£´ËÍ⣬ËûÃÇ»¹Ê×´ÎÍÆ²â´æÔÚÒ»ÖÖÓëDNAÐòÁÐÏ໥²¹¡¢Äܽ«ËüËù±àÂëµÄÒÅ´«ÐÅÏ¢´øµ½µ°°×Öʺϳɳ¡Ëù£¨Ï¸°ûÖÊ£©²¢·Òë²úÉúµ°°×ÖʵÄmRNA£¨ÐÅʹºËÌǺËËᣩ¡£ JQ"U4GVp
1972Ä꣬Paul Berg£¨ÃÀ£©µÚÒ»´Î½øÐÐÁËDNAÖØ×é¡£ 5LOo8xN
1977Ä꣬SangerºÍGilbert£¨Ó¢£©µÚÒ»´Î½øÐÐÁËDNAÐòÁзÖÎö¡£ KZ/=IP=
1988Ä꣬McClintockÓÉÓÚÔÚ50Äê´úÌá³ö²¢·¢ÏÖÁË¿ÉÒÆ¶¯ÒÅ´«Òò×Ó£¨jumping gene»ò³Æmobile element£©¶ø»ñµÃNobel½±¡£ >y,-v:Vy
1993Ä꣬ÃÀ¹ú¿ÆÑ§¼ÒRobertsºÍSharpÒò·¢ÏÖ¶ÏÁÑ»ùÒò£¨introns£©¶ø»ñµÃNobel½±¡£MullisÓÉÓÚ·¢Ã÷PCRÒǶøÓë¼ÓÄôóѧÕßSmith£¨µÚÒ»¸öÉè¼Æ»ùÒò¶¨µãÍ»±ä£©¹²ÏíNobel»¯Ñ§½±¡£ D-c`F
G'
´ËÍ⣬Griffith£¨1928£©¼°Avery£¨1944£©µÈÈ˹ØÓÚÖ²¡Á¦Ç¿µÄ¹â»¬ÐÍ£¨SÐÍ£©·ÎÑ×Á´Çò¾úDNAµ¼ÖÂÖ²¡Á¦ÈõµÄ´Ö²ÚÐÍ£¨RÐÍ£©Ï¸¾ú·¢ÉúÒÅ´«×ª»¯µÄʵÑ飻HersheyºÍChase£¨1952£©¹ØÓÚDNAÊÇÒÅ´«ÎïÖʵÄʵÑ飻CrickÓÚ1954ÄêËùÌá³öµÄÒÅ´«ÐÅÏ¢´«µÝ¹æÂÉ£¨¼´ÖÐÐÄ·¨Ôò£©:MeselsonºÍStahl£¨1958£©¹ØÓÚDNA°ë±£Áô¸´ÖƵÄʵÑéÒÔ¼°YanofskyºÍBrener£¨1961£©Äê¹ØÓÚÒÅ´«ÃÜÂëÈýÁª×ÓµÄÉèÏ붼Ϊ·Ö×ÓÉúÎïѧµÄ·¢Õ¹×ö³öÁËÖØ´ó¹±Ïס£ P-9<YN
ÎÒ¹úÉúÎï¿ÆÑ§¼ÒÎâÏÜ20ÊÀ¼Í20Äê´ú³õ»Ø¹úºóÔÚкÍÒ½¿Æ´óѧÉú»¯ÏµÓëÍôéà¡¢ÕŲýÓ±µÈÈËÒ»µÀÍê³ÉÁ˵°°×ÖʱäÐÔÀíÂÛ¡¢ÑªÒºÉú»¯¼ì²âºÍÃâÒß»¯Ñ§µÈһϵÁÐÓÐÖØ´óÓ°ÏìµÄÑо¿£¬³ÉΪÎÒ¹úÉúÎﻯѧ½çµÄÏÈÇý¡£20ÊÀ¼Í60Äê´ú¡¢70Äê´úºÍ80Äê´ú£¬ÎÒ¹ú¿ÆÑ§¼ÒÏà¼ÌʵÏÖÁËÈ˹¤È«ºÏ³ÉÓÐÉúÎïѧ»îÐԵĽᾧţÒȵºËØ£¬½â³öÁËÈý·½¶þпÖíÒȵºËصľ§Ìå½á¹¹£¬²ÉÓÃÓлúºÏ³ÉÓëø´ÙÏà½áºÏµÄ·½·¨Íê³ÉÁ˽Íĸ±û°±Ëá×ªÒÆºËÌǺËËáµÄÈ˹¤È«ºÏ³É£¬ÔÚøѧÑо¿¡¢µ°°×Öʽṹ¼°ÉúÎïĤ½á¹¹Ó빦Äܵȷ½Ãæ¶¼ÓÐÊÀËùÖõÄ¿µÄ½¨Ê÷¡£ <i,U )Tt^C
6O
y$gW)
Èý¡¢·Ö×ÓÉúÎïѧµÄÖ÷ÒªÑо¿ÄÚÈÝ r(P(Rj2~
ËùÓÐÉúÎïÌåÖеÄÓлú´ó·Ö×Ó¶¼ÊÇÒÔ̼Ô×ÓΪºËÐÄ£¬²¢ÒÔ¹²¼Û¼üµÄÐÎʽÓëÇâ¡¢Ñõ¡¢µª¼°Á×ÒÔ²»Í¬·½Ê½¹¹³ÉµÄ¡£²»½öÈç´Ë£¬Ò»ÇÐÉúÎïÌåÖеĸ÷ÀàÓлú´ó·Ö×Ó¶¼ÊÇÓÉÍêÈ«ÏàͬµÄµ¥Ì壬Èçµ°°×ÖÊ·Ö×ÓÖеÄ20ÖÖ°±»ùËá¡¢DNA¼°RNAÖеÄ8ÖÖ¼î»ùËù×éºÏ¶ø³ÉµÄ£¬Óɴ˲úÉúÁË·Ö×ÓÉúÎïѧµÄ3Ìõ»ù±¾ÔÀí£º soQ1X@"0
1£® ¹¹³ÉÉúÎïÌåÓлú´ó·Ö×ӵĵ¥ÌåÔÚ²»Í¬ÉúÎïÖж¼ÊÇÏàͬµÄ£» >D4#y
2£® ÉúÎïÌåÄÚÒ»ÇÐÓлú´ó·Ö×ӵĽ¨³É¶¼×ñÑן÷×ÔÌØ¶¨µÄ¹æÔò£» jbAx;Xt'=M
3£® Ä³Ò»ÌØ¶¨ÉúÎïÌåËùÓµÓеĺËËá¼°µ°°×ÖÊ·Ö×Ó¾ö¶¨ÁËËüµÄÊôÐÔ¡£ 9E6_]8rl
·Ö×ÓÉúÎïѧÑо¿ÄÚÈÝ: *6>.!&
DNAÖØ×é¼¼Êõ------»ùÒò¹¤³Ì dUhY\v oQ
»ùÒò±í´ïµ÷¿Ø-------ºËËáÉúÎïѧ t;}:waZD
ÉúÎï´ó·Ö×ӽṹ¹¦ÄÜ----½á¹¹·Ö×ÓÉúÎïѧ maN
l^i
DNAÖØ×é¼¼Êõ£¨ÓֳƻùÒò¹¤³Ì£© sc}~8T
ÕâÊÇ20ÊÀ¼Í70Äê´ú³õÐËÆðµÄ¼¼Êõ¿ÆÑ§£¬Ä¿µÄÊǽ«²»Í¬DNAƬ¶Î£¨Èçij¸ö»ùÒò»ò»ùÒòµÄÒ»²¿·Ö£©°´ÕÕÈËÃǵÄÉè¼Æ¶¨ÏòÁ¬½ÓÆðÀ´£¬ÔÚÌØ¶¨µÄÊÜÌåϸ°ûÖÐÓëÔØÌåͬʱ¸´ÖƲ¢µÃµ½±í´ï£¬²úÉúÓ°ÏìÊÜÌåϸ°ûµÄеÄÒÅ´«ÐÔ×´¡£ÑϸñµØËµ£¬DNAÖØ×é¼¼Êõ²¢²»ÍêÈ«µÈÓÚ»ùÒò¹¤³Ì£¬ÒòΪºóÕß»¹°üÀ¨ÆäËû¿ÉÄÜʹÉúÎïϸ°û»ùÒò×é½á¹¹µÃµ½¸ÄÔìµÄÌåϵ¡£DNAÖØ×é¼¼ÊõÊǺËËữѧ¡¢µ°°×ÖÊ»¯Ñ§¡¢Ã¸¹¤³Ì¼°Î¢ÉúÎïѧ¡¢ÒÅ´«Ñ§¡¢Ï¸°ûѧ³¤ÆÚÉîÈëÑо¿µÄ½á¾§£¬¶øÏÞÖÆÐÔÄÚÇÐøDNAÁ¬½Óø¼°ÆäËû¹¤¾ßøµÄ·¢ÏÖÓëÓ¦ÓÃÔòÊÇÕâÒ»¼¼ÊõµÃÒÔ½¨Á¢µÄ¹Ø¼ü¡£ I "A_b}~*}
DNAÖØ×é¼¼ÊõÓÐ׏ãÀ«µÄÓ¦ÓÃǰ¾°:DNAÖØ×é¼¼Êõ¿ÉÓÃÓÚ¶¨Ïò¸ÄÔìijЩÉúÎï»ùÒò×é½á¹¹£¬Ê¹ËüÃÇËù¾ß±¸µÄÌØÊ⾼üÛÖµ»ò¹¦ÄܵÃÒԳɰ٠ÉÏǧ±¶µÄµØÌá¸ß¡£DNAÖØ×é¼¼Êõ»¹±»ÓÃÀ´½øÐлù´¡Ñо¿¡£Èç¹û˵£¬·Ö×ÓÉúÎïѧÑо¿µÄºËÐÄÊÇÒÅ´«ÐÅÏ¢µÄ´«µÝºÍ¿ØÖÆ£¬ÄÇô¸ù¾ÝÖÐÐÄ·¨Ôò£¬ÎÒÃÇÒªÑо¿µÄ¾ÍÊÇ´ÓDNAµ½RNA£¬ÔÙµ½µ°°×ÖʵÄÈ«¹ý³Ì£¬Ò²¼´»ùÒòµÄ±í´ïÓëµ÷¿Ø¡£ÔÚÕâÀÎÞÂÛÊÇ¶ÔÆô¶¯×ÓµÄÑо¿£¨°üÀ¨µ÷¿ØÔª¼þ»ò³ÆË³Ê½×÷ÓÃÔª¼þ£©£¬»¹ÊǶÔת¼Òò×ӵĿË¡¼°·ÖÎö£¬¶¼Àë²»¿ªÖØ×éDNA¼¼ÊõµÄÓ¦Óᣠy2^Y/)
y]f"@9G#
»ùÒò±í´ïµ÷¿ØÑо¿ 9J2NH|]c
ÒòΪµ°°×ÖÊ·Ö×Ó²ÎÓë²¢¿ØÖÆÁËϸ°ûµÄÒ»Çдúл»î¶¯£¬¶ø¾ö¶¨µ°°×ÖʽṹºÍºÏ³ÉʱÐòµÄÐÅÏ¢¶¼ÓɺËËᣨÖ÷ÒªÊÇÍÑÑõºËÌǺËËᣩ·Ö×Ó±àÂ룬±íÏÖÎªÌØ¶¨µÄºËÜÕËáÐòÁУ¬ËùÒÔ»ùÒò±í´ïʵÖÊÉϾÍÊÇÒÅ´«ÐÅÏ¢µÄת¼ºÍ·Òë¡£ÔÚ¸öÌåÉú³¤·¢Óý¹ý³ÌÖÐÉúÎïÒÅ´«ÐÅÏ¢µÄ±í´ï°´Ò»¶¨µÄʱÐò·¢Éú±ä»¯£¨Ê±Ðòµ÷½Ú£©£¬²¢Ëæ×ÅÄÚÍâ»·¾³µÄ±ä»¯¶ø²»¶Ï¼ÓÒÔÐÞÕý£¨»·¾³µ÷¿Ø£©¡£ \hx1o\
ÔºËÉúÎïµÄ»ùÒò×éºÍȾɫÌå½á¹¹¶¼±ÈÕæºËÉúÎï¼òµ¥£¬×ªÂ¼ºÍ·ÒëÔÚͬһʱ¼äºÍ¿Õ¼äÄÚ·¢Éú£¬»ùÒò±í´ïµÄµ÷¿ØÖ÷Òª·¢ÉúÔÚת¼ˮƽ¡£ÕæºËÉúÎïÓÐϸ°ûºË½á¹¹£¬×ªÂ¼ºÍ·Òë¹ý³ÌÔÚʱ¼äºÍ¿Õ¼äÉ϶¼±»·Ö¸ô¿ª£¬ÇÒÔÚת¼ºÍ·Òëºó¶¼Óи´ÔÓµÄÐÅÏ¢¼Ó¹¤¹ý³Ì£¬Æä»ùÒò±í´ïµÄµ÷¿Ø¿ÉÒÔ·¢ÉúÔÚ¸÷ÖÖ²»Í¬µÄˮƽÉÏ¡£»ùÒò±í´ïµ÷¿ØÖ÷Òª±íÏÖÔÚÐźŴ«µ¼Ñо¿¡¢×ªÂ¼Òò×ÓÑо¿¼°RNA¼ô¼3¸ö·½Ãæ¡£ r/u A.Aou^
ת¼Òò×ÓÊÇһȺÄÜÓë»ùÒò5¡¯¶ËÉÏÓÎÌØ¶¨ÐòÁÐרһ½áºÏ£¬´Ó¶ø±£Ö¤Ä¿µÄ»ùÒòÒÔÌØ¶¨µÄÇ¿¶ÈÔÚÌØ¶¨µÄʱ¼äÓë¿Õ¼ä±í´ïµÄµ°°×ÖÊ·Ö×Ó¡£ GJ_7h_
4
ÕæºË»ùÒòÔڽṹÉϵIJ»Á¬ÐøÐÔÊǽü10ÄêÀ´ÉúÎïѧÉϵÄÖØ´ó·¢ÏÖÖ®Ò»¡£µ±»ùÒòת¼³Épre-mRNAºó£¬³ýÁËÔÚ5¡¯¶Ë¼Óñ¼°3¡¯¶Ë¼Ó¶à¾ÛA[polyA]Ö®Í⣬»¹Òª½«¸ô¿ª¸÷¸öÏàÁÚ±àÂëÇøµÄÄÚº¬×Ó¼ôÈ¥£¬Ê¹ÍâÏÔ×Ó£¨±àÂëÇø£©ÏàÁ¬ºó³ÉΪ³ÉÊìmRNA¡£Ñо¿·¢ÏÖ£¬ÓÐÐí¶à»ùÒò²»Êǽ«ËüÃǵÄÄÚº¬×ÓÈ«²¿¼ôÈ¥£¬¶øÊÇÔÚ²»Í¬µÄϸ°û»ò²»Í¬µÄ·¢Óý½×¶ÎÓÐÑ¡ÔñµØ¼ô½ÓÆäÖв¿·ÖÄÚº¬×Ó£¬Òò´ËÉú³É²»Í¬µÄmRNA¼°µ°°×ÖÊ·Ö×Ó¡£ 3R.W>U
T[g[&K1Y
½á¹¹·Ö×ÓÉúÎïѧ ,Vt/(x-
ÉúÎï´ó·Ö×ӵĽṹ¹¦ÄÜÑо¿£¨Óֳƽṹ·Ö×ÓÉúÎïѧ£© Ò»¸öÉúÎï´ó·Ö×Ó£¬ÎÞÂÛÊǺËËá¡¢µ°°×ÖÊ»ò¶àÌÇ£¬ÔÚ·¢»ÓÉúÎïѧ¹¦ÄÜʱ£¬±ØÐë¾ß±¸Á½¸öǰÌá:Ê×ÏÈ£¬ËüÓµÓÐÌØ¶¨µÄ¿Õ¼ä½á¹¹£¨Èýά½á¹¹£©£»Æä´Î£¬ÔÚËü·¢»ÓÉúÎïѧ¹¦ÄܵĹý³ÌÖбض¨´æÔÚ׎ṹºÍ¹¹ÏóµÄ±ä»¯¡£ ?j"KV_
½á¹¹·Ö×ÓÉúÎïѧ¾ÍÊÇÑо¿ÉúÎï´ó·Ö×ÓÌØ¶¨µÄ¿Õ¼ä½á¹¹¼°½á¹¹µÄÔ˶¯±ä»¯ÓëÆäÉúÎïѧ¹¦ÄܹØÏµµÄ¿ÆÑ§¡£Ëü°üÀ¨½á¹¹µÄ²â¶¨¡¢½á¹¹Ô˶¯±ä»¯¹æÂɵÄ̽Ë÷¼°½á¹¹Ó빦ÄÜÏ໥¹ØÏµµÄ½¨Á¢3¸öÖ÷ÒªÑо¿·½Ïò¡£×î³£¼ûµÄÑо¿Èýά½á¹¹¼°ÆäÔ˶¯¹æÂɵÄÊÖ¶ÎÊÇXÉäÏßÑÜÉäµÄ¾§Ìåѧ£¨ÓֳƵ°°×Öʾ§Ìåѧ£©£¬Æä´ÎÊÇÓöþάºË´Å¹²ÕñºÍ¶àάºË´ÅÑо¿ÒºÏà½á¹¹£¬Ò²ÓÐÈËÓõ羵ÈýÎ¬ÖØ×é¡¢µç×ÓÑÜÉä¡¢ÖÐ×ÓÑÜÉäºÍ¸÷ÖÖÆµÆ×ѧ·½·¨Ñо¿ÉúÎï¸ß·Ö×ӵĿռä½á¹¹¡£ 2h5nMI]'
t%E!o0+8Z
,g2ij
V3^&oe%
µÚ¶þ½² ȾɫÌåÓëDNA @`q:IIgW
Ò»¡¢ DNAµÄ×é³ÉÓë½á¹¹ 0Ziw_S\d&s
AveryÔÚ1944ÄêµÄÑо¿±¨¸æÖÐдµÀ£º"µ±ÈÜÒºÖоƾ«µÄÌå»ý´ïµ½9/10ʱ£¬ÓÐÏËά״ÎïÖÊÎö³ö¡£ÈçÉÔ¼Ó½Á°è£¬Ëü¾Í»áÏóÃÞÏßÔÚÏßÖáÉÏÒ»ÑùÈÆÔÚÓ²°ôÉÏ£¬ÈÜÒºÖÐµÄÆäËü³É·ÝÔò³Ê¿ÅÁ£×´³Áµí¡£ÈܽâÏËά״ÎïÖʲ¢Öظ´Êý´Î£¬¿ÉÌá¸ßÆä´¿¶È¡£ÕâÒ»ÎïÖʾßÓкÜÇ¿µÄÉúÎïѧ»îÐÔ£¬³õ²½ÊµÑé֤ʵ£¬ËüºÜ¿ÉÄܾÍÊÇDNA¡£¶ÔDNA·Ö×ÓµÄÎïÀí»¯Ñ§Ñо¿µ¼ÖÂÁËÏÖ´úÉúÎïѧ·Ì츲µØµÄ¸ïÃü£¬Õâ¸üÊÇAveryËùûÓÐÏëµ½¡£ hoK>~:;
ËùνDNAµÄÒ»¼¶½á¹¹£¬¾ÍÊÇÖ¸4ÖÖºËÜÕËáµÄÁ¬½Ó¼°ÆäÅÅÁÐ˳Ðò£¬±íʾÁ˸ÃDNA·Ö×ӵĻ¯Ñ§¹¹³É¡£ºËÜÕËáÐòÁжÔDNA¸ß¼¶½á¹¹µÄÐγÉÓкܴóÓ°Ï죬ÈçB-DNAÖжà¾Û£*****-C£©ÇøÒ׳öÏÖ×óÊÖÂÝÐýDNA£¨Z-DNA£©£¬¶ø·´ÏòÖØ¸´µÄDNAƬ¶ÎÒ׳öÏÖ·¢¿¨Ê½½á¹¹µÈ¡£DNA²»½ö¾ßÓÐÑϸñµÄ»¯Ñ§×é³É£¬»¹¾ßÓÐÌØÊâµÄ¸ß¼¶½á¹¹£¬ËüÖ÷ÒªÒÔÓйæÔòµÄË«ÂÝÐýÐÎʽ´æÔÚ£¬Æä»ù±¾ÌصãÊÇ£º 9_Be0xgJ3^
1¡¢DNA·Ö×ÓÊÇÓÉÁ½Ìõ»¥ÏàÆ½ÐеÄÍÑÑõºËÜÕË᳤Á´ÅÌÈÆ¶ø³ÉµÄ¡£ n>BkTaI
2¡¢DNA·Ö×ÓÖеÄÍÑÑõºËÌǺÍÁ×Ëá½»ÌæÁ¬½Ó£¬ÅÅÔÚÍâ²à£¬¹¹³É»ù±¾¹Ç¼Ü£¬¼î»ùÅÅÁÐÔÚÄڲࡣ U:^PC
x`
3¡¢Á½ÌõÁ´Éϵļî»ùͨ¹ýÇâ¼üÏà½áºÏ£¬Ðγɼî»ù¶Ô£¬ËüµÄ×é³ÉÓÐÒ»¶¨µÄ¹æÂÉ¡£Õâ¾ÍÊÇàÑßÊÓëà×à¤Åä¶Ô£¬¶øÇÒÏÙàÑßÊ£¨A£©Ö»ÄÜÓëÐØÏÙà×ण¨T£©Åä¶Ô£¬ÄñàÑßÊ£*****£©Ö»ÄÜÓë°ûà×ण¨C£©Åä¶Ô¡£ÈçÒ»ÌõÁ´ÉÏijһ¼î»ùÊÇC£¬ÁíÒ»ÌõÁ´ÉÏÓëËüÅä¶ÔµÄ¼î»ù±Ø¶¨ÊÇG¡£¼î»ùÖ®¼äµÄÕâÖÖÒ»Ò»¶ÔÓ¦µÄ¹ØÏµ½Ð¼î»ù»¥²¹Åä¶ÔÔÔò¡£×é³ÉDNA·Ö×ӵļî»ùËäȻֻÓÐ4ÖÖ£¬ËüÃǵÄÅä¶Ô·½Ê½Ò²Ö»ÓÐAÓëT£¬CÓëGÁ½ÖÖ£¬µ«ÊÇ£¬ÓÉÓÚ¼î»ù¿ÉÒÔÈκÎ˳ÐòÅÅÁУ¬¹¹³ÉÁËDNA·Ö×ӵĶàÑùÐÔ¡£ÀýÈ磬ijDNA·Ö×ÓµÄÒ»Ìõ¶àºËÜÕËáÁ´ÓÐ100¸ö²»Í¬µÄ¼î»ù×é³É£¬ËüÃǵĿÉÄÜÅÅÁз½Ê½¾ÍÊÇ4100¡£ t gI{`jS%
j+
$rj
¶þ¡¢ DNA¾ÛºÏøÓëDNAµÄºÏ³É
Rh_np
The accuracy of translation relies on the specificity of base pairing. The actual rate in bacteria seems to be --10-8-10-10. This corresponds to -1 error per genome per 1000 bacterial replication cycles, or -10-6 per gene per generation. |}=acc/
DNA polymerase might improve the specificity of complementary base selection at either (or both) of two stages: -?V-*jI
1£¬It could scrutinize the incoming base for the proper complementarity with the template base; for example, by specifically recongnizing matching chemical features. This would be a presynthetic error control. (k5We!4[1
2£¬Or it could scrutinize the base pair after the new base has been added to the chain, and, in those cases in which a mistake has been made, remove the most recently added base. This would be a proofreading control. D1zBsi94D
}dgfqq
Èý¡¢DNAµÄÉúÀíÒâÒå¼°³É·Ö·ÖÎö kmP]SO?tx
ÔçÔÚ1928ÄêÓ¢¹ú¿ÆÑ§¼ÒGriffithµÈÈ˾ͷ¢ÏÖ·ÎÑ×Á´Çò¾úʹСÊó²Ð·ÏµÄÔÒòÊÇÒýÆð·ÎÑס£Ï¸¾úµÄ¶¾ÐÔ£¨Ö²¡Á¦£©ÊÇÓÉϸ°û±íÃæ¼ÔĤÖеĶàÌÇËù¾ö¶¨µÄ¡£¾ßÓй⻬Íâ±íµÄSÐÍ·ÎÑ×Á´Çò¾úÒòΪ´øÓмÔĤ¶àÌǶø¶¼ÄÜʹСÊó·¢²¡£¬¶ø¾ßÓдֲÚÍâ±íµÄRÐÍÒòΪûÓмÔĤ¶àÌǶøÊ§È¥Ö²¡Á¦£¨¼ÔĤ¶àÌÇÄܱ£»¤Ï¸¾úÃâÊÜÔ˶¯°×ϸ°û¹¥»÷£©¡£ a&/#X9/
Ê×ÏÈÓÃʵÑéÖ¤Ã÷»ùÒò¾ÍÊÇDNA·Ö×ÓµÄÊÇÃÀ¹úÖøÃûµÄ΢ÉúÎïѧ¼ÒAvery¡£AveryµÈÈ˽«¹â»¬ÐÍÖ²¡¾ú£¨SÐÍ£©ÉÕÖóɱÃð»îÐÔÒÔºóÔÙÇÖȾСÊ󣬷¢ÏÖÕâЩËÀϸ¾ú×ÔȻɥʧÁËÖ²¡ÄÜÁ¦¡£ÔÙÓûîµÄ´Ö²ÚÐÍϸ¾ú£¨RÐÍ£©À´ÇÖȾСÊó£¬Ò²²»ÄÜʹ֮·¢²¡£¬ÒòΪ´Ö²ÚÐÍϸ¾úÌìÈ»ÎÞÖ²¡Á¦¡£µ±ËûÃǽ«¾ÉÕÖóɱËÀµÄSÐÍϸ¾úºÍ»îµÄRÐÍϸ¾ú»ìºÏÔÙ¸ÐȾСÊóʱ£¬ÊµÑéСÊóÿ´Î¶¼ËÀÁË¡£½âÆÊËÀÊ󣬷¢ÏÖÓдóÁ¿»îµÄSÐÍ£¨¶ø²»ÊÇRÐÍ£©Ï¸¾ú¡£ËûÃÇÍÆ²â£¬ËÀϸ¾úÖеÄijһ³É·ÖÔæ×ª»¯Ô´£¨transforming principle£©½«ÎÞÖ²¡Á¦µÄϸ¾úת»¯³É²¡Ôϸ¾ú¡£ 2^h27A
ÃÀ¹úÀäȪ¸Û¿¨ÄÚ»ùÒÅ´«Ñ§ÊµÑéÊÒ¿ÆÑ§¼ÒHersheyºÍËûµÄѧÉúChaseÔÚ1952Äê´ÓÊÂÊɾúÌåÇÖȾϸ¾úµÄʵÑé¡£ÊɾúÌåרÃżÄÉúÔÚϸ¾úÌåÄÚ¡£ËüµÄÍ·¡¢Î²Íⲿ¶¼ÓÐÓɵ°°×ÖÊ×é³ÉµÄÍâ¿Ç£¬Í·ÄÚÖ÷ÒªÊÇDNA¡£ÊɾúÌåÇÖȾϸ¾úµÄ¹ý³Ì¿ÉÒÔ·ÖΪÒÔÏÂ5¸ö²½Ö裺¢ÙÊɾúÌåÓÃβ²¿µÄÄ©¶Ë£¨»ùƬ¡¢Î²Ë¿£©Îü¸½ÔÚϸ¾ú±íÃæ£»¢ÚÊɾúÌåͨ¹ýβÖá°ÑDNAÈ«²¿×¢Èëϸ¾úϸ°ûÄÚ£¬ÊɾúÌåµÄµ°°×ÖÊÍâ¿ÇÔòÁôÔÚϸ°ûÍâÃæ£»¢ÛÊɾúÌåµÄDNAÒ»µ©½øÈëϸ¾úÌåÄÚ£¬Ëü¾ÍÄÜÀûÓÃϸ¾úµÄÉúÃü¹ý³ÌºÏ³ÉÊɾúÌå×ÔÉíµÄDNAºÍµ°°×ÖÊ£»¢ÜкϳɵÄDNAºÍµ°°×ÖÊÍâ¿Ç£¬ÄÜ×é×°³ÉÐíÐí¶à¶àÓëÇ×´úÍêÈ«ÏàͬµÄ×ÓÊɾúÌ壻¢Ý×Ó´úÊɾúÌåÓÉÓÚϸ¾úµÄ½âÌå¶ø±»ÊͷųöÀ´£¬ÔÙÈ¥ÇÖȾÆäËûϸ¾ú¡£ËûÃÇ·¢ÏÖ±»¸ÐȾµÄϸ¾úÖдøÓÐ70%µÄÊɾúÌåDNA£¬µ«Ö»´øÓÐ20%µÄÊɾúÌåµ°°×ÖÊ¡£×Ó´úÊɾúÌåÖдøÓÐ50%±ê¼ÇµÄDNA£¬È´Ö»ÓÐ1%µÄ±ê¼Çµ°°×ÖÊ¡£ 7%Gwc?[x
ËÄ. C-valueºÍCot1/2 ;z}i-cNae
D~S<U
BJ$9vbhZN
Îå¡¢ ȾɫÌå½á¹¹ >3_jWFq
ÈκÎÒ»ÌõȾɫÌåÉ϶¼´øÓÐÐí¶à»ùÒò£¬Ò»Ìõ¸ßµÈÉúÎïµÄȾɫÌåÉÏ¿ÉÄÜ´øÓгÉǧÉÏÍò¸ö»ùÒò£¬Ò»¸öϸ°ûÖеÄÈ«²¿»ùÒòÐòÁм°Æä¼ä¸ôÐòÁÐͳ³ÆÎªgenomes£¨»ùÒò×飩¡£ Èç¹ûÉèÏ뽫ÈËÌåϸ°ûÖеÄDNA·Ö×ÓÈÆµØÇòÒ»ÖÜ£¬ÄÇô£¬Ã¿¸ö¼î»ù´óÔ¼Ö»Õ¼1£5ÀåÃ×£¬¶øÒ»¸ö2£3kbµÄ»ùÒòÖ»Ï൱ÓÚµØÇòÉÏÒ»ÌõÊýÊ®Ã׳¤£¬ÊýÀåÃ׿íµÄÏ߶Σ¡ Wbr|_W
8 OY 3A
Genotype (»ùÒòÐÍ)£º The genetic constitution of a given organism (ָij¸öÌØ¶¨ÉúÎïÌåϸ°ûÄÚµÄÈ«²¿ÒÅ´«ÎïÖÊ)¡£ [^Os kJ4
Phenotype (±íÏÖÐÍ)£º Visible property of any given organism (ij¸öÌØ¶¨ÉúÎïÌåÖпɹ۲쵽µÄÎïÀí»òÉúÀíÏÖÏó)¡£ b=yx7v"r
Mutations£º ȾɫÌåDNAÖпÉÒÅ´«µÄºËÜÕËáÐòÁб仯¡£ #5cEV'm;
Rdvk
ml@@
Áù¡¢ ȾɫÌåµÄ×é³É {.?ZHy\Rk
1£®È¾É«ÖʺͺËСÌå H?<N.Dq
ȾɫÖÊDNAµÄTmÖµ±È×ÔÓÉDNA¸ß£¬ËµÃ÷ÔÚȾɫÖÊÖÐDNA¼«¿ÉÄÜÓëµ°°×ÖÊ·Ö×ÓÏ໥×÷Óã»ÔÚȾɫÖÊ״̬Ï£¬ÓÉDNA¾ÛºÏøºÍRNA¾ÛºÏø´ß»¯µÄDNA¸´ÖƺÍת¼»îÐÔ´ó´óµÍÓÚÔÚ×ÔÓÉDNAÖеķ´Ó¦£»DNAøI£¨DNaseI£©¶ÔȾɫÖÊDNAµÄÏû»¯Ô¶Ô¶ÂýÓÚ¶Ô´¿DNAµÄ×÷Óá£È¾É«Öʵĵç×ÓÏÔ΢¾µÍ¼ÏÔʾ³öÓɺËСÌå×é³ÉµÄÄîÖé×´½á¹¹£¬¿ÉÒÔ¿´µ½ÓÉÒ»Ìõϸ˿Á¬½Ó×ŵÄÒ»Á¬´®Ö±¾¶Îª10nmµÄÇò×´Ìå¡£ k1w_[w[
ºËСÌåÊÇÓÉH2A¡¢H2B¡¢H3¡¢H4¸÷Á½¸ö·Ö×ÓÉú³ÉµÄ°Ë¾ÛÌåºÍÓÉ´óÔ¼200bpDNA×é³ÉµÄ¡£°Ë¾ÛÌåÔÚÖм䣬DNA·Ö×ÓÅÌÈÆÔÚÍ⣬¶øH1ÔòÔÚºËСÌåµÄÍâÃæ¡£Ã¿¸öºËСÌåÖ»ÓÐÒ»¸öH1¡£ '\Giv!>
ÔÚºËСÌåÖÐDNAÅÌÈÆ×éµ°°×°Ë¾ÛÌåºËÐÄ£¬´Ó¶øÊ¹·Ö×ÓÊÕËõ³É1/7£¬200bpDNAµÄ³¤¶ÈԼΪ68nm£¬È´±»Ñ¹ËõÔÚ10nmµÄºËСÌåÖС£µ«ÊÇ£¬ÈËÖÐÆÚȾɫÌåÖк¬3.3¡Á109¼î»ù¶Ô£¬ÆäÀíÂÛ³¤¶ÈÓ¦ÊÇ180cm£¬Õâô³¤µÄDNA±»°üº¬ÔÚ46¸ö51¦Ìm³¤µÄÔ²ÖùÌ壨ȾɫÌ壩ÖУ¬ÆäѹËõ±ÈԼΪ104¡£ [I'0,y
gw#5jW\
2£®È¾É«ÌåÖеĺËËá×é³É 27
]':A4_
¢Å²»Öظ´ÐòÁÐ ÔÚµ¥±¶Ìå»ùÒò×éÀÕâЩÐòÁÐÒ»°ãÖ»ÓÐÒ»¸ö»ò¼¸¸ö¿½±´£¬ËüÕ¼DNA×ÜÁ¿µÄ40%£80%¡£²»Öظ´ÐòÁг¤Ô¼750£2000dp£¬Ï൱ÓÚÒ»¸ö½á¹¹»ùÒòµÄ³¤¶È¡£µ¥¿½±´»ùÒòͨ¹ý»ùÒòÀ©ÔöÈԿɺϳɴóÁ¿µÄµ°°×ÖÊ£¬ÈçÒ»¸ö²ÏË¿Ðĵ°°×»ùÒò¿É×÷Ϊģ°åºÏ³É104¸öË¿Ðĵ°°×mRNA£¬Ã¿¸ömRNA¿É´æ»î4d£¬¹²ºÏ³É105¸öË¿Ðĵ°°×£¬ÕâÑù£¬ÔÚ¼¸ÌìÖ®ÄÚ£¬Ò»¸öµ¥¿½±´Ë¿Ðĵ°°×»ùÒò¾Í¿ÉÒԺϳÉ109¸öË¿Ðĵ°°×·Ö×Ó ¡£ ]zj9A]i:a
/oR0+sH]
¢ÆÖжÈÖØ¸´ÐòÁÐ ÕâÀàÖØ¸´ÐòÁеÄÖØ¸´´ÎÊýÔÚ10£104Ö®¼ä£¬Õ¼×ÜDNAµÄ10%£40%¡£¸÷ÖÖrRNA¡¢tRNA ¼°×éµ°°×»ùÒòµÈ¶¼ÊôÕâÒ»Àà¡£ @mOH"acGn?
·ÇÖÞצó¸µÄ18S¡¢5.8S¼°28SrRNA»ùÒòÊÇÁ¬ÔÚÒ»ÆðµÄ£¬Öмä¸ô×Ų»×ªÂ¼µÄ¼ä¸ôÇø£¬ÕâЩµ¥Î»ÔÚDNAÁ´ÉÏ´®ÁªÖظ´Ô¼5000´Î¡£ÔÚÂÑϸ°ûÐγɹý³ÌÖÐÕâЩ»ùÒò¿É½øÐм¸Ç§´Î²»Í¬±ÈÀýµÄ¸´ÖÆ£¬²úÉú2¡Á106¸ö¿½±´£¬Ê¹rDNAÕ¼ÂÑϸ°ûDNAµÄ75%£¬´Ó¶øÊ¹¸Ãϸ°ûÄÜ»ýÀÛ1012¸öºËÌÇÌå¡£ =XA;[PVx:#
PDJr<E?
¢Ç¸ß¶ÈÖØ¸´ÐòÁСª¡ªÎÀÐÇDNA ÕâÀàDNAÖ»ÔÚÕæºËÉúÎïÖз¢ÏÖ£¬Õ¼»ùÒò×éµÄ10%¡ª60%£¬ÓÉ6¡ª100¸ö¼î»ù×é³É£¬ÔÚDNAÁ´ÉÏ´®ÁªÖظ´¼¸°ÙÍò´Î¡£ÓÉÓÚ¼î»ùµÄ×é³É²»Í¬£¬ÔÚCsClÃܶÈÌݶÈÀëÐÄÖÐÒ×ÓëÆäËûDNA·Ö¿ª£¬Ðγɺ¬Á¿½Ï´óµÄÖ÷·å¼°¸ß¶ÈÖØ¸´ÐòÁÐС·å£¬ºóÕßÓÖ³ÆÎÀÐÇÇø´ø£¨·å£©¡£ d"}k
!
0m
¸ßµÈÕæºËÉúÎïDNAÎÞÂ۴ӽṹ»¹Êǹ¦ÄÜ¿´¶¼¼«Îª¸´ÔÓ£¬ÒÔСÊóΪÀý£º e@Fo^#ImDx
1.СÊó×ÜDNAµÄ10£¥ÊÇСÓÚ10bpµÄ¸ß¶ÈÖØ¸´ÐòÁУ¬Öظ´ÊýÊ®Íòµ½ÉϰÙÍò´Î/genome¡£ Yw4n-0g
2.×ÜDNAµÄ20£¥ÊÇÖØ¸´Êýǧ´Î¡¢³¤Ô¼Êý°ÙbpµÄÖеÈÖØ¸´ÐòÁС£ t[ubn+
3.×ÜDNAµÄ70£¥ÊDz»Öظ´»òµÍÖØ¸´ÐòÁÐ,¾ø´ó²¿·Ö¹¦ÄÜ»ùÒò¶¼Î»ÓÚÕâÀàÐòÁÐÖС£ e<3K;Q
Centromere£ºÊÇϸ°ûÓÐË¿·ÖÁÑÆÚ¼ä·Ä´¸Ìåµ°°×ÖÊÓëȾɫÌåµÄ½áºÏλµã£¨attachment point£©£¬ÕâÖÖ½áºÏ¶ÔÓÚȾɫÌå¶ÔÔÚ×Óϸ°ûÖеÄÓÐÐòºÍƽ¾ù·ÖÅäÖÁ¹ØÖØÒª¡£ÔÚ½ÍĸÖУ¬centromereµÄ¹¦Äܵ¥Î»³¤Ô¼130 bp£¬¸»º¬AT ¼î»ù¶Ô¡£ÔڸߵÈÕæºËϸ°ûÖУ¬centromere¶¼ÊÇÓɳ¤Ô¼5£10 bp¡¢·½ÏòÏàͬµÄ¸ß¶ÈÖØ¸´ÐòÁÐËù×é³É¡£ F"&~*m^+
Telomeres are sequences at the ends of eukaryotic Chromosomes that help stabilize them¡£ ½ÍĸTelomeresÒ»°ãÒÔ100 bp×óÓÒ²»¾«È·Öظ´ÐòÁÐËù×é³É¡£ E@@5BEB ~
5¡¯(TxGy)n ',Y.v"']4
3¡¯(AxCy)n Bc+w+
ÆäÖÐX¡¢YÒ»°ãΪ1£4£¬µ¥Ï¸°ûÕæºËÉúÎïÖÐn³£Îª20£100£¬¸ßµÈÕæºËÉúÎïÖÐ>1500¡£ /(u}KMR!f
ȾɫÌåÄ©¶ËµÄÏßÐÔÖØ¸´ÐòÁв»Äܱ»DNA polymarase Ëù׼ȷ¸´ÖÆ£¬ËüÃÇÒ»°ãÔÚDNA¸´ÖÆÍê³ÉÒÔºóÓÉtelomaraseºÏ³Éºó¼Óµ½È¾É«ÌåÄ©¶Ë¡£ _,p/l&<
Alu£¨³¤Ô¼300bp£©ÊÇÈËÀà¸ß¶ÈÖØ¸´ÐòÁÐ,ÒòΪ¸ÃÐòÁÐÖдøÓÐAluIµÄʶ±ðÐòÁжøµÃÃû¡£ÊýÊ®Íò¸öAluÖØ¸´ÐòÁÐÉ¢²¼ÓÚÕû¸öÈËÀà»ùÒò×éÖУ¬´ïµ½×ÜÐòÁеÄ1£3£¥¡£AluÓëÆäËü¸ß¶ÈÖØ¸´ÐòÁй²Õ¼ÈËÀàDNAµÄ10£¥ÒÔÉÏ¡£ VCY\be
[$qyF|/K`n
3£®È¾É«ÌåÖеĵ°°×ÖÊ 4" Cb/y3
ȾɫÌåÉϵĵ°°×ÖʰüÀ¨×éµ°°×ºÍ·Ç×éµ°°×¡£×éµ°°×ÊÇȾɫÌåµÄ½á¹¹µ°°×£¬ËüÓëDNA×é³ÉºËСÌ塣ͨ³£¿ÉÒÔÓÃ2mol/L NaCl»ò0.25mol/LµÄHCl/H2SO4´¦Àíʹ×éµ°°×ÓëDNA·Ö¿ª¡£×éµ°°×·ÖΪH1¡¢H2A¡¢H2B¡¢H3¼°H4¡£ÕâЩ×éµ°°×¶¼º¬ÓдóÁ¿µÄÀµ°±ËáºÍ¾«°±ËᣬÆäÖÐH3¡¢H4¸»º¬¾«°±ËᣬH1¸»º¬Àµ°±Ë᣻H2A¡¢H2B½éÓÚÁ½ÕßÖ®¼ä¡£
gp5_Z-me
¢Å×éµ°°×µÄÒ»°ãÌØÐÔ ]JCvyz
H
½ø»¯Éϵļ«¶Ë±£ÊØÐÔ¡£Å£¡¢Öí¡¢´óÊóµÄH4°±»ùËáÐòÁÐÍêÈ«Ïàͬ¡£Å£µÄH4ÐòÁÐÓëÍã¶¹ÐòÁÐÏà±ÈÖ»ÓÐÁ½¸ö°±»ùËáµÄ²îÒ죨Íã¶¹H4ÖеÄÒìÁÁ°±»ùËá60¡úçÓ°±Ëá60£¬¾«°±Ëá¡úÀµ°±Ëᣩ¡£H3µÄ±£ÊØÐÔÒ²ºÜ´ó£¬ÀðÓãÓëÐ¡Å£ÐØÏÙµÄH3Ö»²îÒ»¸ö°±»ùËá£¬Ð¡Å£ÐØÏÙÓëÍã¶¹H3Ö»²î4¸ö°±»ùËá¡£ s3~lT.
ÎÞ×éÖ¯ÌØÒìÐÔ¡£µ½Ä¿Ç°ÎªÖ¹£¬½ö·¢ÏÖÄñÀà¡¢ÓãÀ༰Á½ÆÜÀàºìϸ°ûȾɫÌå²»º¬H1¶ø´øÓÐH5£¬¾«Ï¸°ûȾɫÌåµÄ×éµ°°×ÊÇÓ㾫µ°°×¡£ kStnb?nk
ëÄÁ´Éϰ±»ùËá·Ö²¼µÄ²»¶Ô³ÆÐÔ¡£¼îÐÔ°±»ùËἯÖзֲ¼ÔÚN¶ËµÄ°ëÌõÁ´ÉÏ¡£ÀýÈ磬N¶ËµÄ°ëÌõÁ´ÉϾ»µçºÉΪ+16£¬C¶ËÖ»ÓÐ+3£¬´ó²¿·ÖÊèË®»ùÍŶ¼·Ö²¼ÔÚC¶Ë¡£ (61EDKNd9
×éµ°°×µÄÐÞÊÎ×÷ÓᣰüÀ¨¼×»ù»¯¡¢ÒÒ»ù»¯¡¢Á×Ëữ¼°ADPºËÌÇ»ù»¯µÈ¡£ )Q1"\\2j0
dCE0$3'5
¢Æ·Ç×éµ°°×µÄÒ»°ãÌØÐÔ 1;C+$
ȾɫÌåÉϳýÁË´æÔÚ´óÔ¼ÓëDNAµÈÁ¿µÄ×éµ°°×ÒÔÍ⣬»¹´æÔÚ´óÁ¿µÄ·Ç×éµ°°×¡£·Ç×éµ°°×µÄ¶àÑùÐÔ¡£·Ç×éµ°°×µÄÁ¿´óÔ¼ÊÇ×éµ°°×µÄ60%¡«70%£¬µ«ËüµÄÖÖÀàÈ´ºÜ¶à£¬Ô¼ÔÚ20-100ÖÖÖ®¼ä£¬ÆäÖг£¼ûµÄÓÐ15-20ÖÖ¡£ ·Ç×éµ°°×µÄ×é֯רһÐÔºÍÖÖÊôרһÐÔ¡£ u?4:H=;>
(3)¼¸Àà³£¼ûµÄ·Ç×éµ°°× _2hS";K
a.HMGµ°°×£¨high mobility group protein£©¡£ÕâÊÇÒ»ÀàÄÜÓõÍÑΣ¨0.35mol/L NaCl£©ÈÜÒº³éÌá¡¢ÄÜÈÜÓÚ2%µÄÈýÂÈÒÒËá¡¢Ïà¶Ô·Ö×ÓÖÊÁ¿½ÏµÍµÄ·Ç×éµ°°×£¬Ïà¶Ô·Ö×ÓÖÊÁ¿¶¼ÔÚ3.0¡Á104ÒÔÏ¡£ H<VTa? n
b. DNA½áºÏµ°°×¡£ÓÃ2mol/L NaCl³ýȥȫ²¿×éµ°°×ºÍ70%·Ç×éµ°°×ºó£¬»¹ÓÐÒ»²¿·Öµ°°×±ØÐëÓÃ2mol/L NaClºÍ5mol/LÄòËØ²ÅÄÜÓëDNA½âÀë¡£ÕâЩµ°°×·Ö×ÓÁ¿½ÏµÍ£¬Ô¼Õ¼·Ç×éµ°°×µÄ20%£¬È¾É«ÖʵÄ8%¡£ [BWNRC1
\#f<!R4
Æß. ÔºËÓëÕæºËȾɫÌåDNA±È½Ï 4 8:>NW
ÔºËÉúÎïÖÐÒ»°ãÖ»ÓÐÒ»ÌõȾɫÌåÇÒ´ó¶¼´øÓе¥¿½±´»ùÒò£¬Ö»ÓкÜÉÙÊý»ùÒò¡²ÈçrRNA»ùÒò¡³ÊÇÒԶ࿽±´ÐÎʽ´æÔÚ£» 3 jGWkby0
Õû¸öȾɫÌåDNA¼¸ºõÈ«²¿Óɹ¦ÄÜ»ùÒòÓëµ÷¿ØÐòÁÐËù×é³É£» gbI^2=YT'
¼¸ºõÿ¸ö»ùÒòÐòÁж¼ÓëËüËù±àÂëµÄµ°°×ÖÊÐòÁгÊÏßÐÔ¶ÔӦ״̬¡£ qs1 ?IYD
Viral DNA molecules are relatively small G'oG</A
HIV = 9000 nt RNA YUx.BZf7
Q¦Â = 4200 nt
]^Qn
Bactaria DNA is 100 times > than viral >[9J?H
E. coli 4639221 bp double-stranded 6N",-c
Contour length = 1.7mm, 850±¶Ï¸¾ú±¾Éí³¤¶È¡£Ï¸¾úÖг£³£´øÓÐÖÊÁ£DNA¡£ 4[.oPK=i
Eucaryotic cells F<L
EQ7T
¹ûÓ¬´øÓÐ25±¶ÓÚE. Coli µÄDNA,ÈËÀà´øÓÐ600±¶ÓÚE. Coli µÄDNA. Eucaryotic DNA ÖлùÒòÃܶÈÃ÷ÏÔµÍÓÚԺ˺Ͳ¡¶¾¡£ÈçÈËDNAÖÐÆ½¾ùÿºÁÃ×Ö»´øÓÐ50¸ö»ùÒò,¶øE. ColiÖлùÒòÃܶÈÿºÁÃ×DNA´øÓÐ2400¸ö»ùÒò£¡Ò»¸öÈËϸ°ûÖÐËù´øÓеÄDNAÔ¼ÓÐ2m/1.7mmϸ¾ú¡£³ÉÈË´øÓÐ1X10^14¸öϸ°û£¬³ÉÈËÌåÄÚÈ«²¿DNAµÄ×ܳ¤¶È£¨Contour Length£©£½ 2X10^11Km 3?c3<`TW
Q~OxH'>>(
8"U. Hnu
6%t1b M
a
------------------------------------------------------ |_] Q$q[[%
GO__$%~
µÚÈý½² µ°°×ÖÊºÏ³É { vKLAxc
Ò».»ùÒòÓë»ùÒò±í´ïµÄÒ»°ã¸ÅÄî -&3hEv5
»ùÒò×÷ΪΨһÄܹ»×ÔÖ÷¸´ÖÆ¡¢ÓÀ¾Ã´æÔڵĵ¥Î»£¬ÆäÉúÀíѧ¹¦ÄÜÒÔµ°°×ÖÊÐÎʽµÃµ½±í´ï¡£DNAÐòÁÐÊÇÒÅ´«ÐÅÏ¢µÄÖü´æÕߣ¬Ëüͨ¹ý×ÔÖ÷¸´ÖƵõ½ÓÀ´æ£¬²¢Í¨¹ýת¼Éú³ÉmRNA£¬·ÒëÉú³Éµ°°×ÖʵĹý³Ì¿ØÖÆËùÓÐÉúÃüÏÖÏó¡£ gLE:g5v6
±àÂëÁ´£¨coding strand£©ÓÖ³Æsense strand£¬ÊÇÖ¸ÓëmRNAÐòÁÐÏàͬµÄÄÇÌõÁ´¡£·Ç±àÂëÁ´£¨anticoding strand£©£¬ÓÖ³Æantisense strand£¬ÊÇÖ¸ÄÇÌõ¸ù¾Ý¼î»ù»¥²¹ÔÔòÖ¸µ¼mRNAÉúÎïºÏ³ÉµÄDNAÁ´¡£ %K>,xiD)
Genetic information is perpetuated by replication£¨¸´ÖÆ£©in which a double- stranded nucleic acid is duplicated to give identical copies. s!?`T1L
»ùÒò±í´ï°üÀ¨×ªÂ¼£¨transcription£©ºÍ·Ò루translation£©Á½¸ö½×¶Î¡£×ªÂ¼ÊÇÖ¸¿½±´³öÒ»ÌõÓëDNAÁ´ÐòÁÐÍêÈ«Ïàͬ£¨³ýÁËT¡úUÖ®Í⣩µÄRNAµ¥Á´µÄ¹ý³Ì£¬ÊÇ»ùÒò±í´ïµÄºËÐIJ½Öè¡£·ÒëÊÇÖ¸ÒÔÐÂÉúµÄmRNAΪģ°å£¬°ÑºËÜÕËáÈýÁª×ÓÒÅ´«ÃÜÂë·Òë³É°±»ùËáÐòÁС¢ºÏ³Éµ°°×ÖʶàëÄÁ´µÄ¹ý³Ì£¬ÊÇ»ùÒò±í´ïµÄ×îÖÕÄ¿µÄ¡£ jBgP$g
Ö»ÓÐmRNAËùЯ´øµÄÒÅ´«ÐÅÏ¢²Å±»ÓÃÀ´Ö¸µ¼µ°°×ÖÊÉúÎïºÏ³É£¬ËùÒÔÈËÃÇÒ»°ãÓÃU¡¢C¡¢A¡¢GÕâ4ÖÖºËÜÕËá¶ø²»ÊÇT¡¢C¡¢A¡¢GµÄ×éºÏÀ´±íʾÒÅ´«ÐÔ×´¡£Ëùν·ÒëÊÇÖ¸½«mRNAÁ´ÉϵĺËÜÕËá´ÓÒ»¸öÌØ¶¨µÄÆðʼλµã¿ªÊ¼£¬°´Ã¿3¸öºËÜÕËá´ú±íÒ»¸ö°±»ùËáµÄÔÔò£¬ÒÀ´ÎºÏ³ÉÒ»Ìõ¶àëÄÁ´µÄ¹ý³Ì¡£ !9[>L@#G
{4G%:09~J
¶þ. ÒÅ´«ÃÜÂ롪¡ªÈýÁª×Ó <~6h|F8
mRNAÉÏÿ3¸öºËÜÕËá·Òë³Éµ°°×ÖʶàëÄÁ´ÉϵÄÒ»¸ö°±»ùËᣬÕâ3¸öºËÜÕËá¾Í³ÆÎªÒ»¸öÃÜÂ룬Ҳ½ÐÈýÁª×ÓÃÜÂë¡£·Òëʱ´ÓÆðʼÃÜÂë×ÓAUG¿ªÊ¼£¬ÑØmRNA5¡¯¡ú3¡¯µÄ·½ÏòÁ¬ÐøÔĶÁÖ±µ½ÖÕÖ¹ÃÜÂë×Ó£¬Éú³ÉÒ»Ìõ¾ßÓÐÌØ¶¨ÐòÁеĶàëÄÁ´¡£ ;nodjbr,j
mRNAÖÐÖ»ÓÐ4ÖÖºËÜÕËᣬ¶øµ°°×ÖÊÖÐÓÐ20ÖÖ°±»ùËᣬÈôÒÔÒ»ÖÖºËÜÕËá´ú±íÒ»ÖÖ°±»ùËᣬֻÄÜ´ú±í4ÖÖ(41=4)¡£ÈôÒÔÁ½ÖÖºËÜÕËá×÷Ϊһ¸öÃÜÂ루¶þÁª×Ó£©£¬ÄÜ´ú±í42=16ÖÖ°±»ùËá¡£¶ø¼Ù¶¨ÒÔ3¸öºËÜÕËá´ú±íÒ»¸ö°±»ùËᣬÔò¿ÉÒÔÓÐ43=64ÖÖÃÜÂ룬Âú×ãÁ˱àÂë20ÖÖ°±»ùËáµÄÐèÒª¡£ :pGaFWkvO
50-60Äê´úÆÆÒëÒÅ´«ÃÜÂë·½ÃæµÄÈýÏîÖØÒª³É¹û£º l|/ep:x8
£¨1£©Paul ZamecnikµÈÈË֤ʵϸ°ûÖе°°×Öʺϳɵij¡Ëù¡£ËûÃǰѷÅÉäÐÔ±ê¼ÇµÄ°±»ùËá×¢Éäµ½´óÊóÌåÄÚ£¬¾¹ýÒ»¶Îʱ¼äºóÊÕ»ñÆä¸ÎÔ࣬½øÐÐÕáÌÇÌݶȳÁµí²¢·ÖÎö¸÷ÖÖϸ°û³É·ÝÖеķÅÉäÐÔµ°°×ÖÊ¡£ l8I /0`_
Èç¹û×¢Éäºó¾ÊýСʱ£¨»òÊýÌ죩ÊÕ»ñ¸ÎÔ࣬ËùÓÐϸ°û³É·ÝÖж¼´øÓзÅÉäÐÔ±ê¼ÇµÄµ°°×ÖÊ; G&i!Hs
Èç¹û×¢Éäºó¼¸·ÖÖÓÄÚ¼´ÊÕ»ñ¸ÎÔ࣬ÄÇô£¬·ÅÉäÐÔ±ê¼ÇÖ»´æÔÚÓÚº¬ÓкËÌÇÌå¿ÅÁ£µÄϸ°ûÖʳɷÝÖС£ 1DE1.1
£¨2£©Francis CrickµÈÈ˵ÚÒ»´Î֤ʵֻÓÐÓÃÈýÁª×ÓÃÜÂëµÄÐÎʽ²ÅÄܰѰüº¬ÔÚÓÉAUGCËĸö×Öĸ×é³ÉÒÅ´«ÐÅÏ¢£¨ºËËᣩ׼ȷÎÞÎ󵨷Òë³ÉÓÉ20ÖÖ²»Í¬°±»ùËá×é³ÉµÄµ°°×ÖÊÐòÁУ¬ÊµÏÖÒÅ´«ÐÅÏ¢µÄ±í´ï¡£ *:Vq:IU[D
ʵÑé1: Hkwl>R$
ÓÃß¹à¤ÀàÊÔ¼Á£¨ÓÕµ¼ºËÜÕËá²åÈë»ò¶ªÊ§£©´¦ÀíT4ÊɾúÌårIIλµãÉϵÄÁ½¸ö»ùÒò£¬Ê¹Ö®·¢ÉúÒÆÂëÍ»±ä£¨frame-shift£©£¬¾ÍÉú³ÉÍêÈ«²»Í¬µÄ¡¢Ã»Óй¦Äܵĵ°°×ÖÊ¡£ .!f$
\1l
ʵÑé2: F<qz[,]|-j
Ñо¿Ñ̲ݻµËÀÎÀÐDz¡¶¾·¢ÏÖ£¬ÆäÍâ¿Çµ°°×ÑÇ»ùÓÉ400¸ö°±»ùËá×é³É£¬ÏàÓ¦µÄRNAƬ¶Î³¤1200¸öºËÜÕËᣬÓëÃÜÂëÈýÁª×ÓÌåϵÕýºÃÏàÎǺϡ£ (Tn- >).AO
ʵÑé3: \#Pf
j&*
ÒÔ¾ù¾ÛÎïΪģ°åÖ¸µ¼¶àëĵĺϳɡ£ ÔÚº¬ÓÐtRNA¡¢ºËÌÇÌå¡¢AA-tRNAºÏ³Éø¼°ÆäËüµ°°×ÖÊÒò×ÓµÄϸ°û³éÌáÎïÖмÓÈëmRNA»òÈ˹¤ºÏ³ÉµÄ¾ù¾ÛÎï×÷Ϊģ°åÒÔ¼°ATP¡¢GTP¡¢°±»ùËáµÈ³É·ÖʱÓÖÄܺϳÉеÄëÄÁ´£¬ÐÂÉúëÄÁ´µÄ°±»ùËá˳ÐòÓÉÍâ¼ÓµÄÄ£°åÀ´¾ö¶¨¡£ ) L#i%)+
1961Ä꣬NirenbergµÈÒÔpoly£¨U£©×÷Ä£°åʱ·¢ÏֺϳÉÁ˶à¾Û±½±û°±Ëᣬ´Ó¶øÍƳöUUU´ú±í±½±û°±ËᣨPhe£©¡£ÒÔpoly£¨C£©¼°poly£¨A£©×öÄ£°å·Ö±ðµÃµ½¶à¾Û¸¬°±ËáºÍ¶à¾ÛÀµ°±Ëá¡£ X~lVVBO
ʵÑé4: t.7?
ÒÔÌØ¶¨ÐòÁеĹ²¾ÛÎïΪģ°åÖ¸µ¼¶àëĵĺϳɡ£ÒÔ¶à¾Û¶þºËÜÕËá×÷Ä£°å¿ÉºÏ³ÉÓÉ2¸ö°±»ùËá×é³ÉµÄ¶àëÄ£¬ <eQj`
HL
5¡¯¡UGU GUG UGU GUG UGU GUG¡3¡¯,²»¹Ü¶ÁÂë´ÓU¿ªÊ¼»¹ÊÇ´ÓG¿ªÊ¼£¬¶¼Ö»ÄÜÓÐUGU£¨Cys£©¼°GUG£¨Val£©Á½ÖÖÃÜÂë×Ó¡£ -I&m:A$4*
ʵÑé5: fA+,TEB~d
ÒÔ¹²¾ÛÈýºËÜÕËá×÷Ϊģ°å¿ÉµÃµ½ÓÐ3ÖÖ°±»ùËá×é³ÉµÄ¶àëÄ¡£ÈçÒÔ¶à¾Û£¨UUC£©ÎªÄ£°å£¬¿ÉÄÜÓÐ3ÖÖÆð¶Á·½Ê½£º =<?+#-;p
5¡¯¡UUC UUC UUC UUC UUC¡3¡¯»ò 5¡¯¡UCU UCU UCU UCU UCU¡3¡¯»ò 5¡¯¡CUU CUU CUU CUU CUU¡3¡¯·Ö±ð²úÉúUUC£¨Phe£©¡¢UCU£¨Ser£©»òCUU£¨Leu£©. $npT[~U5
¶à¾ÛÈýºËÜÕËáΪģ°åʱҲ¿ÉÄÜÖ»ºÏ³É2ÖÖ¶àëÄ£º5¡¯¡GUA GUA GUA GUA GUA¡3¡¯»ò5¡¯¡UAG UAG UAG UAG UAG¡3¡¯ sg$rzT-S4
»ò5¡¯¡AGU AGU AGU AGU AGU¡3¡¯ÓɵڶþÖÖ¶ÁÂ뷽ʽ²úÉúµÄÃÜÂë×ÓUAGÊÇÖÕÖ¹ÃÜÂ룬²»±àÂëÈκΰ±»ùËᣬÒò´Ë£¬Ö»²úÉúGUA£¨Val£©»òAGU£¨Ser£©¡£ A-ZN F4
ʵÑé6: n/+.s(7c
ÒÔËæ»ú¶à¾ÛÎïÖ¸µ¼¶àëĺϳɡ£NirenbergµÈ¼°OchoaµÈÓÖÓø÷ÖÖËæ»úµÄ¶à¾ÛÎï×÷Ä£°åºÏ³É¶àëÄ¡£ÀýÈ磬ÒÔÖ»º¬A¡¢CµÄ¶à¾ÛºËÜÕËá×÷Ä£°å£¬ÈÎÒâÅÅÁÐʱ¿É³öÏÖ8ÖÖÈýÁª×Ó£¬¼´CCC¡¢CCA¡¢CAC¡¢ACC¡¢CAA¡¢ACA¡¢AAC¡¢AAA£¬»ñµÃÓÉAsn¡¢His¡¢Pro¡¢Gln¡¢Thr¡¢LysµÈ6ÖÖ°±»ùËá×é³ÉµÄ¶àëÄ¡£ +VO-oFE |
Dey<OE&
£¨3£©°±»ùËáµÄ¡°»î»¯¡±ÓëºËÌÇÌå½áºÏ¼¼Êõ¡£ xlA$:
M&
Èç¹û°Ñ°±»ùËáÓëATPºÍ¸ÎÔàϸ°ûÖʹ²ÅàÑø£¬°±»ùËá¾Í»á±»¹Ì¶¨ÔÚijЩÈÈÎȶ¨ÇÒ¿ÉÈÜÐÔRNA·Ö×Ó£¨transfer RNA£¬tRNA£©ÉÏ¡£ÏÖ½«°±»ùËá»î»¯ºóµÄ²úÎï³ÆÎª°±»ùõ£-tRNA£¨aminoacyl-tRNA£©£¬²¢°Ñ´ß»¯¸Ã¹ý³ÌµÄø³ÆÎª°±»ùõ£ºÏ³Éø£¨aminoacyl-tRNA Synthetase£©¡£ sj HrPs e
ÒÔÈ˹¤ºÏ³ÉµÄÈýºËÜÕËáÈçUUU¡¢UCU¡¢UGUµÈΪģ°å£¬ÔÚº¬ºËÌÇÌå¡¢AA-tRNAµÄ·´Ó¦ÒºÖб£Îºóͨ¹ýÏõËáÏËÎ¬ËØÂËĤ£¬Ö»ÓÐÓÎÀëµÄAA-tRNAÒòÏà¶Ô·Ö×ÓÖÊÁ¿Ð¡¶øÍ¨¹ýÂËĤ£¬¶øºËÌÇÌå»òÓëºËÌÇÌå½áºÏµÄAA-tRNAÔòÁôÔÚÂËĤÉÏ£¬ÕâÑù¿É°ÑÒѽáºÏÓëδ½áºÏµÄAA-tRNA·Ö¿ª¡£ mt,OniU= Q
µ±ÌåϵÖдøÓжà¾ÛºËÜÕËáÄ£°åʱ£¬´Ó´ó³¦¸Ë¾úÖÐÌáÈ¡µÄºËÌÇÌå¾³£ÓëÌØÒìÐÔ°±»ùõ£-tRNAÏà½áºÏ¡£Èç¹û°ÑºËÌÇÌåÓëpoly£¨U£©ºÍPhe-tRNAPhe¹²ÎÂÓý£¬ºËÌÇÌå¾ÍÄÜͬʱÓëpoly£¨U£©ºÍPhe-tRNAPheÏà½áºÏ¡£ j2QmxTa!
4ÖÖºËÜÕËá×é³É61¸ö±àÂë°±»ùËáµÄÃÜÂë×ÓºÍ3¸öÖÕÖ¹ÃÜÂë×Ó£¬ËüÃDz»ÄÜÓëtRNAµÄ·´ÃÜÂë×ÓÅä¶Ô£¬µ«Äܱ»ÖÕÖ¹Òò×Ó»òÊÍ·ÅÒò×Óʶ±ð£¬ÖÕÖ¹ëÄÁ´µÄºÏ³É¡£ÓÉÒ»ÖÖÒÔÉÏÃÜÂë×Ó±àÂëͬһ¸ö°±»ùËáµÄÏÖÏó³ÆÎª¼ò²¢£¨degeneracy£©£¬¶ÔÓ¦ÓÚͬһ°±»ùËáµÄÃÜÂë×Ó³ÆÎªÍ¬ÒåÃÜÂë×Ó£¨synonymous codon£©¡£ 4nh>'v%pD
OmIg<v0\;
Èý£®ÃÜÂë×Ӻͷ´ÃÜÂë×ÓµÄÏ໥×÷Óà BYVY)<v/
µ°°×ÖÊÉúÎïºÏ³É¹ý³ÌÖУ¬tRNAµÄ·´ÃÜÂë×Óͨ¹ý¼î»ùµÄ·´ÏòÅä¶ÔÓëmRNAµÄÃÜÂë×ÓÏ໥×÷Óá£1966Ä꣬Crick¸ù¾ÝÁ¢Ì廯ѧÔÀíÌá³ö°Ú¶¯¼Ù˵£¨wobble hypothesis£©£¬½âÊÍÁË·´ÃÜÂë×ÓÖÐijЩϡÓгɷÖÈçIÒÔ¼°Ðí¶àÓÐ2¸öÒÔÉÏͬԴÃÜÂë×ÓµÄÅä¶ÔÎÊÌâ¡£ LR".pH13
Wobble hypothesis
^,/RO5
¢Ù ÈÎÒâÒ»¸öÃÜÂë×ÓµÄǰÁ½Î»¼î»ù¶¼ÓëtRNA anticodonÖеÄÏàÓ¦¼î»ùÐγÉWatson-Crick¼î»ùÅä¶Ô¡£ ?~hHGf\^b6
¢Ú ·´ÃÜÂë×ÓµÚһλÊÇA»òCʱ£¬Ö»ÄÜʶ±ðÒ»¸öÃÜÂë×Ó¡£µ±·´ÃÜÂë×ÓµÚһλÊÇU»òGʱ£¬ÄÜʶ±ðÁ½¸öÃÜÂë×Ó¡£µ±Inosine£¨I£©×÷Ϊ·´ÃÜÂë×ÓµÚһλʱ£¬ÄÜʶ±ðÈý¸öÃÜÂë×Ó¡£ g^}8:,F_
¢Û Èç¹ûÊý¸öÃÜÂë×Óͬʱ±àÂëÒ»¸ö°±»ùËᣬ·²ÊǵÚÒ»¡¢¶þλ¼î»ù²»ÏàͬµÄÃÜÂë×Ó¶¼¶ÔÓ¦ÓÚ¸÷×ÔµÄtRNA¡£ G
8g<>d{j
¢Ü ¸ù¾ÝÉÏÊö¹æÔò£¬ÖÁÉÙÐèÒª32ÖÖ²»Í¬µÄtRNA²ÅÄÜ·Òë61¸öÃÜÂë×Ó¡£ ;/r1}tl+3>
Kx;eaz:gx
ËÄ£®tRNA +trC,D
tRNAÔÚµ°°×ÖʺϳÉÖд¦ÓڹؼüµØÎ»£¬±»³ÆÎªµÚ¶þÒÅ´«ÃÜÂë¡£Ëü²»µ«Îª½«Ã¿¸öÈýÁª×ÓÃÜÂë·Òë³É°±»ùËáÌṩÁ˽ӺÏÌ壬»¹Îª×¼È·ÎÞÎ󵨽«ËùÐè°±»ùËáÔËË͵½ºËÌÇÌåÉÏÌṩÁËÔØÌå¡£ËùÓеÄtRNA¶¼Äܹ»ÓëºËÌÇÌåµÄPλµãºÍAλµã½áºÏ£¬´Ëʱ£¬tRNA·Ö×ÓÈýÒ¶²ÝÐͶ¥¶ËÍ»Æð²¿Î»Í¨¹ýÃÜÂë×Ó£º·´ÃÜÂë×ÓµÄÅä¶ÔÓëmRNAÏà½áºÏ£¬¶øÆä3¡¯Ä©¶ËÇ¡ºÃ½«ËùתÔ˵ݱ»ùËáË͵½ÕýÔÚÑÓÉìµÄ¶àëÄÉÏ¡£´ú±íÏàͬ°±»ùËáµÄtRNA³ÆÎªÍ¬¹¤tRNA¡£ÔÚÒ»¸öͬ¹¤tRNA×éÄÚ£¬ËùÓÐtRNA¾ùרһÓÚÏàͬµÄ°±»ùõ£- tRNAºÏ³Éø¡£ -*
WXMzr
1¡¢tRNAµÄÈýÒ¶²ÝÐͶþ¼¶½á¹¹ n1ly
y0%u
ÊÜÌå±Û£¨acceptor arm£©Ö÷ÒªÓÉÁ´Á½¶ËÐòÁмî»ùÅä¶ÔÐγɵĸË×´½á¹¹ºÍ3¡¯¶ËÄ©Åä¶ÔµÄ3-4¸ö¼î»ùËù×é³É£¬Æä3¡¯¶ËµÄ×îºó3¸ö¼î»ùÐòÁÐÓÀÔ¶ÊÇCCA£¬×îºóÒ»¸ö¼î»ùµÄ3¡¯»ò2¡¯×ÔÓÉôÇ»ù£¨¡ªOH£©¿ÉÒÔ±»°±õ£»¯¡£T¦ÕC±ÛÊǸù¾Ý3¸öºËÜÕËáÃüÃûµÄ£¬ÆäÖЦձíʾÄâÄòà×ण¬ÊÇtRNA·Ö×ÓËùÓµÓеIJ»³£¼ûºËÜÕËá¡£·´ÃÜÂë×Ó±ÛÊǸù¾ÝλÓÚÌ×Ë÷ÖÐÑëµÄÈýÁª·´ÃÜÂë×ÓÃüÃûµÄ¡£D±ÛÊǸù¾ÝËüº¬ÓжþÇâÄòà×ण¨dihydrouracil£©ÃüÃûµÄ¡£ w5A y)lz
×î³£¼ûµÄtRNA·Ö×ÓÓÐ76¸ö¼î»ù£¬Ïà¶Ô·Ö×ÓÖÊÁ¿Ô¼Îª2.5¡Á104¡£²»Í¬µÄtRNA·Ö×Ó¿ÉÓÐ74-95¸öºËÜÕËá²»µÈ£¬tRNA·Ö×Ó³¤¶ÈµÄ²»Í¬Ö÷ÒªÊÇÓÉÆäÖеÄÁ½ÌõÊÖ±ÛÒýÆðµÄ¡£tRNAµÄÏ¡Óмî»ùº¬Á¿·Ç³£·á¸»£¬Ô¼ÓÐ70ÓàÖÖ¡£Ã¿¸ötRNA·Ö×ÓÖÁÉÙº¬ÓÐ2¸öÏ¡Óмî»ù£¬×î¶àÓÐ19¸ö£¬¶àÊý·Ö²¼ÔÚ·ÇÅä¶ÔÇø£¬ÌرðÊÇÔÚ·´ÃÜÂë×Ó3¡¯¶ËÁÚ½ü²¿Î»³öÏֵįµÂÊ×î¸ß£¬ÇÒ´ó¶àΪàÑßʺËÜÕËá¡£Õâ¶ÔÓÚά³Ö·´ÃÜÂë×Ó»·µÄÎȶ¨ÐÔ¼°ÃÜÂë×Ó¡¢·´ÃÜÂë×ÓÖ®¼äµÄÅä¶ÔÊǺÜÖØÒªµÄ¡£ ~Y|*`C_)
2£®tRNAµÄLÐÎÈý¼¶½á¹¹ k <=//r
½ÍĸºÍ´ó³¦¸Ë¾útRNAµÄÈý¼¶½á¹¹¶¼³ÊLÐÎÕÛµþʽ¡£ÕâÖֽṹÊÇ¿¿Çâ¼üÀ´Î¬³ÖµÄ£¬tRNAµÄÈý¼¶½á¹¹ÓëAA- tRNAºÏ³ÉøµÄʶ±ðÓйء£ÊÜÌå±ÛºÍT¦ÕC±ÛµÄ¸Ë×´ÇøÓò¹¹³ÉÁ˵ÚÒ»¸öË«ÂÝÐý£¬D±ÛºÍ·´ÃÜÂë×ӱ۵ĸË×´ÇøÓòÐγÉÁ˵ڶþ¸öË«ÂÝÐý¡£ eYN5;bx
)W
tRNAµÄLÐθ߼¶½á¹¹·´Ó³ÁËÆäÉúÎïѧ¹¦ÄÜ£¬ÒòΪËüÉÏËùÔËÔØµÄ°±»ùËá±ØÐë¿¿½üλÓÚºËÌÇÌå´óÑÇ»ùÉϵĶàëĺϳÉλµã£¬¶øËüµÄ·´ÃÜÂë×Ó±ØÐëÓëСÑÇ»ùÉϵÄmRNAÏàÅä¶Ô£¬ËùÒÔÁ½¸ö²»Í¬µÄ¹¦ÄÜ»ùÍÅ×î´óÏÞ¶È·ÖÀë¡£ /aZ+T5O
3£®tRNAµÄ¹¦ÄÜ "alyfyBu'M
ת¼¹ý³ÌÊÇÐÅÏ¢´ÓÒ»ÖÖºËËá·Ö×Ó£¨DNA£©×ªÒÆÖÁÁíÒ»ÖֽṹÉϼ«ÎªÏàËÆµÄºËËá·Ö×Ó£¨RNA£©µÄ¹ý³Ì£¬ÐÅÏ¢×ªÒÆ¿¿µÄÊǼî»ùÅä¶Ô¡£·Òë½×¶ÎÒÅ´«ÐÅÏ¢´ÓmRNA·Ö×Ó×ªÒÆµ½½á¹¹¼«²»ÏàͬµÄµ°°×ÖÊ·Ö×Ó£¬ÐÅÏ¢ÊÇÒÔÄܱ»·Òë³Éµ¥¸ö°±»ùËáµÄÈýÁª×ÓÃÜÂëÐÎʽ´æÔڵģ¬ÔÚÕâÀïÆð×÷ÓõÄÊǽâÂë»úÖÆ¡£ JtEo'As:[
4£®tRNAµÄÖÖÀà 5ni~Q 9b
£¨1£©ÆðʼtRNAºÍÑÓÉìtRNA UNom-
ÄÜÌØÒìµØÊ¶±ðmRNAÄ£°åÉÏÆðʼÃÜÂë×ÓµÄtRNA½ÐÆðʼtRNA£¬ÆäËûtRNAͳ³ÆÎªÑÓÉìtRNA¡£ÔºËÉúÎïÆðʼtRNAЯ´ø¼×õ£¼×Áò°±ËᣨfMet£©£¬ÕæºËÉúÎïÆðʼtRNAЯ´ø¼×Áò°±ËᣨMet£©¡£ [d(U38BI
£¨2£©Í¬¹¤tRNA +av@$}
´ú±íͬһÖÖ°±»ùËáµÄtRNA³ÆÎªÍ¬¹¤tRNA£¬Í¬¹¤tRNA¼ÈÒªÓв»Í¬µÄ·´ÃÜÂë×ÓÒÔʶ±ð¸Ã°±»ùËáµÄ¸÷ÖÖͬÒåÃÜÂ룬ÓÖÒªÓÐijÖֽṹÉϵĹ²Í¬ÐÔ£¬Äܱ»AA- tRNAºÏ³Éøʶ±ð¡£ rH_\d?b
£¨3£©Ð£ÕýtRNA eg(6^
:z?f
УÕýtRNA·ÖΪÎÞÒåÍ»±ä¼°´íÒåÍ»±äУÕý¡£ qf!p 9@4F[
ÔÚµ°°×ÖʵĽṹ»ùÒòÖУ¬Ò»¸öºËÜÕËáµÄ¸Ä±ä¿ÉÄÜʹ´ú±íij¸ö°±»ùËáµÄÃÜÂë×Ó±ä³ÉÖÕÖ¹ÃÜÂë×Ó£¨UAG¡¢UGA¡¢UAA£©£¬Ê¹µ°°×ÖʺϳÉÌáǰÖÕÖ¹£¬ºÏ³ÉÎÞ¹¦ÄܵĻòÎÞÒâÒåµÄ¶àëÄ£¬ÕâÖÖÍ»±ä¾Í³ÆÎªÎÞÒåÍ»±ä¡£ w<Wf?a G
8$6Y{$&C
Î壮AA- tRNAºÏ³Éø ÊÇÒ»Àà´ß»¯°±»ùËáÓëtRNA½áºÏµÄÌØÒìÐÔø£¬Æä·´Ó¦Ê½ÈçÏ£º pGJ>O/%
Ëüʵ¼ÊÉϰüÀ¨Á½²½·´Ó¦£º ([SU:F!uW(
µÚÒ»²½Êǰ±»ùËá»î»¯Éú³Éø-°±»ùõ£ÏÙÜÕËḴºÏÎï¡£ _jLL_GD
AA+ATP+ø£¨E£©¡úE-AA-AMP+PPi QZ6D7tUc8
µÚ¶þ²½Êǰ±õ£»ù×ªÒÆµ½tRNA 3¡¯Ä©¶ËÏÙÜղлùÉÏ£¬ÓëÆä2¡¯»ò3¡¯-ôÇ»ù½áºÏ¡£ =Xi07_8Ic<
E-AA-AMP+ tRNA¡úAA- tRNA +E+AMP Qw-~>d
µ°°×ÖʺϳɵÄÕæÊµÐÔÖ÷Òª¾ö¶¨ÓÚAA- tRNAºÏ³ÉøÊÇ·ñÄÜʹ°±»ùËáÓë¶ÔÓ¦µÄtRNAÏà½áºÏ¡£AA-tRNAºÏ³Éø¼ÈÒªÄÜʶ±ðtRNA£¬ÓÖÒªÄÜʶ±ð°±»ùËᣬËü¶ÔÁ½Õß¶¼¾ßÓи߶ȵÄרһÐÔ¡£²»Í¬µÄtRNAÓв»Í¬¼î»ù×é³ÉºÍ¿Õ¼ä½á¹¹£¬ÈÝÒ×±»tRNAºÏ³ÉøËùʶ±ð£¬À§ÄѵÄÊÇÕâЩøÈçºÎʶ±ð½á¹¹ÉϷdz£ÏàËÆµÄ°±»ùËá¡£ dIN$)?aB0
ÓÐÁ½µÀ¹Ø¿Ú: iII=;:p
The first filter is the initial binding of the amino acid to the enzyme and its activation to aminoacyl-AMP. }& cu/o4
The second filter is the binding of incorrect aminoacyl-AMP products to a separate active site on the enzyme. ,K)_OVB
mq@6Q\Z+
ºËÌÇÌåÏñÒ»¸öÄÜÑØmRNAÄ£°åÒÆ¶¯µÄ¹¤³§£¬Ö´ÐÐ×ŵ°°×ÖʺϳɵŦÄÜ¡£ËüÊÇÓɼ¸Ê®ÖÖµ°°×Öʺͼ¸ÖÖºËÌÇÌåRNA£¨ribosomal RNA£¬rRNA£©×é³ÉµÄÑÇϸ°û¿ÅÁ£¡£Ò»¸öϸ¾úϸ°ûÄÚÔ¼ÓÐ20000¸öºËÌÇÌ壬¶øÕæºËϸ°ûÄÚ¿É´ï106¸ö£¬ÔÚδ³ÉÊìµÄó¸òÜÂÑϸ°ûÄÚÔò¸ß´ï1012¡£ºËÌÇÌåºÍËüµÄ¸¨ÖúÒò×ÓΪµ°°×ÖʺϳÉÌṩÁ˱ØÒªÌõ¼þ¡£ T ]t'39
vHyC; 4'
1.ºËÌÇÌåµÄ×é³É R3x3]]D
ÔºËÉúÎïºËÌÇÌåÓÉÔ¼2/3µÄRNA¼°1/3µÄµ°°×ÖÊ×é³É¡£ÕæºËÉúÎïºËÌÇÌåÖÐRNAÕ¼3/5£¬µ°°×ÖÊÕ¼2/5¡£ºËÌÇÌåÊÇÒ»¸öÖÂÃܵĺËÌǺ˵°°×¿ÅÁ££¬¿ÉÒÔ½âÀëΪÁ½¸öÑÇ»ù£¬Ã¿¸öÑÇ»ù¶¼º¬ÓÐÒ»¸öÏà¶Ô·Ö×ÓÖÊÁ¿½Ï´óµÄrRNAºÍÐí¶à²»Í¬µÄµ°°×ÖÊ·Ö×Ó¡£ hs^zTZ_
´ó³¦¸Ë¾úºËÌÇÌåСÑÇ»ùÓÉ21ÖÖµ°°×ÖÊ×é³É£¬·Ö±ðÓÃS1¡¡S21±íʾ£¬´óÑÇ»ùÓÉ33ÖÖµ°°×ÖÊ×é³É£¬·Ö±ðÓÃL1¡¡L33±íʾ¡£ÕæºËÉúÎïϸ°ûºËÌÇÌå´óÑÇ»ùº¬ÓÐ49ÖÖµ°°×ÖÊ£¬Ð¡ÑÇ»ùÓÐ33ÖÖµ°°×ÖÊ¡£
gbF+WE
2¡¢rRNA z@!`:'ak
3.ºËÌÇÌåµÄ¹¦ÄÜ [@VP?74
ºËÌÇÌå°üÀ¨ÖÁÉÙ5¸ö»îÐÔÖÐÐÄ£¬¼´mRNA½áºÏ²¿Î»¡¢½áºÏ»ò½ÓÊÜAA- tRNA²¿Î»£¨A룩¡¢½áºÏ»ò½ÓÊÜëÄ»ùtRNAµÄ²¿Î»¡¢ëÄ»ù×ªÒÆ²¿Î»£¨P룩¼°ÐγÉëļüµÄ²¿Î»£¨×ªëÄøÖÐÐÄ£©£¬´ËÍ⻹ÓиºÔðëÄÁ´ÑÓÉìµÄ¸÷ÖÖÑÓÉìÒò×ӵĽáºÏλµã¡£Ð¡ÑÇ»ùÉÏÓµÓÐmRNA½áºÏλµã£¬¸ºÔð¶ÔÐòÁÐÌØÒìµÄʶ±ð¹ý³Ì£¬ÈçÆðʼλµãµÄʶ±ðºÍÃÜÂë×ÓÓë·´ÃÜÂë×ÓµÄÏ໥×÷ÓᣴóÑÇ»ù¸ºÔð°±»ùËá¼°tRNAЯ´øµÄ¹¦ÄÜ£¬ÈçëļüµÄÐγɡ¢AA- tRNA¡¢ëÄ»ù- tRNAµÄ½áºÏµÈ¡£Aλ¡¢Pλ¡¢×ªëÄøÖÐÐĵÈÖ÷ÒªÔÚ´óÑÇ»ùÉÏ¡£ 8aK)#tNWN
ºËÌÇÌå¿É½âÀëΪÑÇ»ù»ò½áºÏ³É70S/80S¿ÅÁ£¡£·ÒëµÄÆðʼ½×¶ÎÐèÒªÓÎÀëµÄÑÇ»ù£¬Ëæºó²Å½áºÏ³É70S/80S¿ÅÁ££¬¼ÌÐø·Òë½ø³Ì¡£ÌåÍâ·´Ó¦ÌåϵÖУ¬ºËÌÇÌåµÄ½âÀë»ò½áºÏÈ¡¾öÓÚMg2+Àë×ÓŨ¶È¡£Ôڴ󳦸˾úÄÚ£¬Mg2+Ũ¶ÈÔÚ10-3mol/LÒÔÏÂʱ£¬70S½âÀëΪÑÇ»ù£¬Å¨¶È´ï10-2mol/LʱÔòÐγÉÎȶ¨µÄ70S¿ÅÁ£¡£Ï¸°ûÖдó¶àÊýºËÌÇÌå´¦ÓÚ·Ç»îÐÔµÄÎȶ¨×´Ì¬£¬µ¥¶À´æÔÚ£¬Ö»ÓÐÉÙÊýÓëmRNAÒ»ÆðÐγɶà¾ÛºËÌÇÌå¡£Ëü´ÓmRNAµÄ5¡¯Ä©¶ËÏò3¡¯Ä©¶ËÔĶÁÃÜÂë×Ó£¬ÖÁÖÕÖ¹×ÓʱºÏ³ÉÒ»ÌõÍêÕûµÄ¶àëÄÁ´¡£mRNAÉϺËÌÇÌåµÄ¶àÉÙÊÓmRNAµÄ³¤¶Ì¶ø¶¨£¬Ò»°ã40¸öºËÜÕËáÓÐÒ»¸öºËÌÇÌå¡£ _zY#U9
.~~nUu+M
Æß. ÐÅʹºËÌǺËËá 6 Q%jA7
mRNA messenger ribonucleic acidDNA deoxyribonucleic acid. bo2H]PL*
ËäÈ»mRNAÔÚËùÓÐϸ°ûÄÚÖ´ÐÐ×ÅÏàͬµÄ¹¦ÄÜ£¬¼´Í¨¹ýÈýÁª×ÓÃÜÂë·ÒëÉú³Éµ°°×ÖÊ£¬ÆäÉúÎïºÏ³ÉµÄ¾ßÌå¹ý³ÌºÍ³ÉÊìmRNAµÄ½á¹¹ÔÚԺ˺ÍÕæºËÉúÎïϸ°ûÄÚÊDz»Í¬µÄ¡£ ^uKwB;@
8EW_V$>R
°Ë¡¢µ°°×ÖʵÄÉúÎïºÏ³É ux
XBEq;
ºËÌÇÌåÊǵ°°×Öʺϳɵij¡Ëù£¬mRNAÊǵ°°×ÖʺϳɵÄÄ£°å£¬tRNAÊÇÄ£°åÓë°±»ùËáÖ®¼äµÄ½ÓºÏÌå¡£´ËÍ⣬ÓÐ20ÖÖÒÔÉϵÄAA-tRNA¼°ºÏ³Éø¡¢10¶àÖÖÆðʼÒò×Ó¡¢ÑÓÉìÒò×Ó¼°ÖÕÖ¹Òò×Ó£¬30¶àÖÖtRNA¼°¸÷ÖÖrRNA¡¢mRNAºÍ100ÖÖÒÔÉÏ·Òëºó¼Ó¹¤Ã¸²ÎÓëµ°°×Öʺϳɺͼӹ¤¹ý³Ì¡£ Vr]id
µ°°×ÖʺϳÉÏûºÄÁËϸ°ûÖÐ90%×óÓÒÓÃÓÚÉúÎïºÏ³É·´Ó¦µÄÄÜÁ¿¡£Ï¸¾úϸ°ûÖеÄ2Íò¸öºËÌÇÌ壬10Íò¸öµ°°×ÖÊÒò×ÓºÍ20Íò¸ötRNAs Ô¼Õ¼´ó³¦¸Ë¾ú¸ÉÖØµÄ35%¡£ K'L^;z6
Ôڴ󳦸˾úÖкϳÉÒ»¸ö100¸ö°±»ùËáµÄ¶àëÄÖ»Ðè5·ÖÖÓ¡£ ) pzy
3eb%OEMYk
1.µ°°×ÖÊÉúÎïºÏ³ÉµÄÖ÷Òª²½Ö裺 ^yW L,$
·ÒëµÄÆðʼ¡ª¡ªºËÌÇÌåÓëmRNA½áºÏ²¢Óë°±»ùõ£-tRNAÉú³ÉÆðʼ¸´ºÏÎï¡£ëÄÁ´µÄÑÓÉ졪¡ªºËÌÇÌåÑØmRNA5¡¯¶ËÏò3¡¯¶ËÒÆ¶¯£¬µ¼Ö´ÓN¶ËÏòC¶ËµÄ¶àëĺϳɡ£ëÄÁ´µÄÖÕÖ¹ÒÔ¼°ëÄÁ´µÄÊÍ·Å¡ª¡ªºËÌÇÌå´ÓmRNAÉϽâÀ룬׼±¸ÐÂÒ»Âֺϳɷ´Ó¦¡£ 6.sx?Y YM
Ö÷Òª·ÖΪÎå²½ {#ZlM
1¡¢ Activation of Amino Acids (This reaction takes place in the cytosol, not on the ribosome). RSfQNc9Z
2¡¢ Initiation. The mRNA bearing the code for the polypeptide binds to the small ribosomal subunit and to the initiating aminoacyl-tRNA. T. }1/S"m
3¡¢Elongation. Peptide bonds are formed in this stage. F^WP <0C
4¡¢Termination and Release. Completion of the polypeptide chain is signaled by a termination codon in the mRNA. Vx$ \hcG
5¡¢Folding and Post translational Processing. ;y,5k?
ëÄÁ´ÑÓÉì·ÖΪÈý²½ t)~"4]{*}D
¢Ù Binding of an incoming aminoacyl-tRNA. ,BH@j%Jmy
¢Ú Peptide bond formation. <`.X$r*
¢Û Translocation. QX!-B
Lb!Fcf|h
2.Óëµ°°×ÖʺϳÉÓйصÄÒò×Ó C_(
*>!Z%
ÆðʼÒò×ÓInitiation factor£¨IF£©ÑÓÉìÒò×ÓElongation factor£¨EF£©ÖÕÖ¹Òò×Ó¡£ÔºËÖÐÓÐRF1-3¡£RF-1 ʶ±ð UAAºÍUAG; RF-2 ʶ±ð UAAºÍUGA; RF-3 ½öÄÜ´Ù½øRF-1ºÍRF-2µÄ¹¦ÄÜ¡£ÖÕÖ¹Òò×ÓÐÐʹ¹¦ÄÜʱÐèÒªGTP¡£ÕæºËÉúÎïÖÐÖ»ÓÐÒ»¸öRF£¬ÄÜʶ±ð3¸öÖÕÖ¹×Ó¡£ DGRXd#
T/b6f;t-s
3¡¢µ°°×ÖÊºÏ³ÉµÄÆðʼ /
z4$gb7Y
µ°°×ÖÊºÏ³ÉµÄÆðʼ¸´ºÏÎï: 3-[q4R
30S ºËÌÇÌåСÑÇ»ù N nRD|A
Ä£°åmRNA S'k_olx7
fMet-tRNAfMet QqDC4+p"
ÆðʼÒò×Ó 6hw=
GTP h`]Iy
50S ºËÌÇÌå´óÑÇ»ù ]GMe\n
Mg2+ lsgh#x
ºÏ³ÉµÄÆðʼ¿É·ÖΪÈý²½: aAZZ8V
1¡¢30S ºËÌÇÌåСÑÇ»ùÓëÆðʼÒò×ÓIF ¨C1ºÍIF-3Ïà½áºÏ£¬ÓÕ·¢Ä£°åmRNAÓëСÑÇ»ù½áºÏ¡£ FTX=Wyr
2¡¢ÓÉ30S СÑÇ»ù¡¢ÆðʼÒò×ÓIF ¨C1ºÍIF-3¼°Ä£°åmRNAËù×é³ÉµÄ¸´ºÏÎïÁ¢¼´ÓëGTP-IF-2¼°fMet-tRNAfMetÏà½áºÏ¡£·´ÃÜÂë×ÓÓëÃÜÂë×ÓÅä¶Ô¡£ :nh_k4S@v
3¡¢ÉÏÊöÁù×é·Ö¸´ºÏÎïÔÙÓë50S´óÑÇ»ù½áºÏ£¬Ë®½âGTPÉú³É²¢ÊÍ·ÅGDPºÍPi¡£ÊÍ·ÅÈý¸öÆðʼÒò×Ó¡£ F5LuSy+v
$~~Jw]
±í27-9 ÕæºËϸ°ûÖвÎÓë·ÒëÆðʼµÄµ°°×ÖÊÒò×Ó¼°Æä¹¦ÄÜ w;;BSJ]+[
rxVanDb=W
ÕæºËÒò×Ó ¹¦ÄÜ &SIq2>Q A
eIF2 ´Ù½øMet-tRNAMetÓëºËÌÇÌå40SСÑÇ»ù½áºÏ¡£ J}*,HT *
eIF2B ++bf#qS<8D
eIF3 c%^7!FSg
ÊÇ×îÔçÓëºËÌÇÌå40SСÑÇ»ù½áºÏµÄ´Ù½øÒò×Ó£¬µ°°×Öʺϳɷ´Ó¦µÄÕý³£½øÐС£ |Z|-q"Rf
eIF4A ¾ßÓÐRNA½âÐýø»îÐÔ£¬½â³ýmRNAÄ£°åµÄ´Î¼¶½á¹¹²¢Ê¹Ö®Óë40SСÑÇ»ù½áºÏ£¬ÐγÉeIF4F¸´ºÏÎï¡£ niiA7Ux
eIF4B ÓëmRNAÄ£°åÏà½áºÏ£¬ÐÖúºËÌÇÌåɨÃèÄ£°åÐòÁУ¬¶¨Î»AUG¡£ c CSs
eIF4E ÓëmRNA 5¡¯µÄñ×ӽṹÏà½áºÏ£¬ÐγÉeIF4F¸´ºÏÎï¡£ 2n,*Nd`
eIF4G ÓëeIF4EºÍpoly£¨A£©½áºÏµ°°×£¨PAB£©Ïà½áºÏ£¬ÐγÉeIF4F¸´ºÏÎï¡£ ; PF`Wj
eIF5 ´Ùʹ¶à¸öµ°°×Òò×ÓÓë40SСÑÇ»ù½âÌ壬ÒԴ˰ïÖú´óСÑÇ»ù½áºÏÐγÉ80ºËÌÇÌ壬ÐγɷÒëÆðʼ¸´ºÏÎï¡£ 45=bGf#
eIF6 ´Ù½øÃ»Óе°°×ÖʺϳɻîÐÔµÄ80SºËÌÇÌå½âÀë³É40SºÍ60SÁ½¸öÑÇ»ù¡£ wc0jhHZO
?
V8e>l[tH
¡¡4¡¢ëÄÁ´µÄÑÓÉì <m!h&_eg
ëÄÁ´ÑÓÉìµÄ»ù±¾ÒªÇóÊÇ £º Z_PNI#h*
ÓÐÍêÕûµÄÆðʼ¸´ºÏÎ Rh3eLt~|(
Óа±»ùõ£-tRNA£¬ CWf /H)~
ÓÐÑÓÉìÒò×ÓEF-Tu, EF-TsºÍEF-G£¬ v:EB*3n5
ÓÐGTP¡£ ~{*7"o/
qBU-~"2t
ëÄÁ´ÑÓÉìÒ²¿É±»·ÖΪÈý²½£º eiuSvyY
µÚÒ»²½£¬ÓëнøÀ´µÄ°±»ùõ£-tRNAÏà½áºÏ¡£°±»ùõ£-tRNAÊ×ÏȱØÐëÓëGTP-EF-Tu¸´ºÏÎïÏà½áºÏ£¬Ðγɰ±»ùõ£-tRNA-GTP-EF-Tu¸´ºÏÎï²¢Óë70SÖеÄAλµãÏà½áºÏ¡£´Ëʱ£¬GTPË®½â²¢ÊÍ·ÅGDP-EF-Tu¸´ºÏÎï¡£ 3ovWwZ8&
µÚ¶þ²½£¬ëļüÐγɡ£ ëļüÐγÉÖ®³õ£¬Á½¸ö°±»ùËáÈÔÈ»·Ö±ðÓë¸÷×ÔµÄtRNAÏà½áºÏ£¬ÈÔÈ»·Ö±ðλÓÚAλµãºÍPλµãÉÏ¡£AλµãÉϵݱ»ùËᣨµÚ¶þ¸ö°±»ùËᣩÖеĦÁ-°±»ù×÷ΪÇ׺˻ùÍÅÈ¡´úÁËPλµãÉϵÄtRNA£¬²¢ÓëÆðʼ°±»ùËáÖеÄCOOH»ùÍÅÐγÉëļü¡£±¾·´Ó¦¿ÉÄÜÓÉpeptidyl transferase ´ß»¯¡£ VGLaN%|
µÚÈý²½£¬ÒÆÎ»£¨translocation£©¡£ ºËÌÇÌåÏòmRNAµÄ3¡¯·½ÏòÒÆ¶¯Ò»¸öÃÜÂë×Ó£¬Ê¹µÃ´øÓеڶþ¸ö°±»ùËᣨÏÖÒѳÉΪ¶þëÄ£©µÄtRNA´ÓAλ½øÈëP룬²¢Ê¹µÚÒ»¸ötRNA´ÓPλ½øÈëEλ¡£´Ëʱģ°åÉϵĵÚÈý¸öÃÜÂë×ÓÕýºÃÔÚAλÉÏ¡£ºËÌÇÌåµÄÒÆÎ»ÐèÒªEF-G£¨translocase£©ºÍÁíÒ»·Ö×ÓGTPË®½âÌṩÄÜÁ¿¡£ 'QG xd!4
/;{P}-H`ei
5¡¢ëÄÁ´µÄÖÕÖ¹ k=2Lo
µ±ÖÕÖ¹ÃÜÂë×Ó½øÈëºËÌÇÌåAλµãʱ£¬ÔÚÊÍ·ÅÒò×ÓRF1-3µÄ×÷ÓÃÏ£º {.n"Z
£¨1£©Ë®½âÄ©¶ËëÄ»ùtRNA£» rjl`&POqc
£¨2£©ÊÍ·ÅÐÂÉúëĺÍtRNA£» ImCe K
£¨3£©Ê¹70SºËÌÇÌå½âÀë³É30SºÍ50SÁ½¸öÑÇ»ù¡£ <3(LWxw
C#QpQg2
6¡¢µ°°×ÖʺϳɵÄÒÖÖÆ¼Á z_g~
¿¹¾úËØ¶Ôµ°°×ÖʺϳɵÄ×÷ÓÿÉÄÜÊÇ×èÖ¹mRNAÓëºËÌÇÌå½áºÏ£¨ÂÈÃ¹ËØ£©£¬»ò×èÖ¹AA-tRNAÓëºËÌÇÌå½áºÏ£¨ËÄ»·ËØÀࣩ£¬»ò¸ÉÈÅAA-tRNAÓëºËÌÇÌå½áºÏ¶ø²úÉú´í¶Á£¨Á´Ã¹ËØ¡¢ÐÂÃ¹ËØ¡¢¿¨ÄÇÃ¹ËØµÈ£©£¬»ò×÷Ϊ¾ºÕùÐÔÒÖÖÆ¼ÁÒÖÖÆµ°°×Öʺϳɡ£ KTK <gV9:
Á´Ã¹ËØÊÇÒ»ÖÖ¼îÐÔÈýÌÇ£¬¸ÉÈÅfMet-tRNAÓëºËÌÇÌåµÄ½áºÏ£¬´Ó¶ø×èÖ¹µ°°×ÖʺϳɵÄÕýÈ·Æðʼ£¬²¢µ¼ÖÂmRNAµÄ´í¶Á¡£ÈôÒÔpoly£¨U£©×÷Ä£°å£¬Ôò³ý±½±û°±ËᣨUUU£©Í⣬ÒìÁÁ°±ËᣨAUU£©Ò²»á²ôÈë¡£¶ÔÁ´Ã¹ËØÃô¸ÐλµãÔÚ30SÑÇ»ùÉÏ¡£ bf0+
DvIB
àÑßÊÃ¹ËØÊÇAA-tRNAµÄ½á¹¹ÀàËÆÎÄܽáºÏÔÚºËÌÇÌåµÄAλÉÏ£¬ÒÖÖÆAA-tRNAµÄ½øÈë¡£ËüËù´øµÄ°±»ùÓëAA- tRNAÉϵݱ»ùÒ»Ñù£¬ÄÜÓëÉú³¤ÖÐëÄÁ´ÉϵÄôÈ»ùÉú³Éëļü£¬Õâ¸ö·´Ó¦µÄ²úÎïÊÇÒ»Ìõ3¡¯ôÈ»ù¶Ë¹ÒÁËÒ»àÑßÊÃ¹ËØ¡£ J`^ag'
ÇàÃ¹ËØ¡¢ËÄ»·ËغͺìÃ¹ËØÖ»ÓëÔºËϸ°ûºËÌÇÌå·¢Éú×÷Ó㬴Ӷø×è¶ôÔºËÉúÎïµ°°×Öʵĺϳɣ¬ÒÖÖÆÏ¸¾úÉú³¤¡£ÂÈÃ¹ËØºÍàÑßÊÃ¹ËØ¼ÈÄÜÓëÔºËϸ°ûºËÌÇÌå½áºÏ£¬ÓÖÄÜÓëÕæºËÉúÎïºËÌÇÌå½áºÏ£¬·Á°Ï¸°ûÄÚµ°°×Öʺϳɣ¬Ó°Ïìϸ°ûÉú³¤¡£Òò´Ë£¬Ç°3ÖÖ¿¹ÉúËØ±»¹ã·ºÓÃÓÚÈËÀàҽѧ£¬ºóÁ½ÖÖÔòºÜÉÙÔÚҽѧÉÏʹÓᣠliEPCWl&
`id9j
--------------------------------------- ,"2s` YC
%el"BSB
µÚËĽ² DNA¡¢RNAºÍµ°°×ÖÊ´úл %mL-$*
DNAÊÇÖü²ØÒÅ´«ÐÅÏ¢µÄ×îÖØÒªµÄÉúÎï´ó·Ö×Ó¡£DNA·Ö×ÓÖеĺËÜÕËáÅÅÁÐ˳Ðò²»µ«¾ö¶¨Á˰ûÄÚËùÓÐRNA¼°µ°°×ÖʵĻù±¾½á¹¹£¬»¹Í¨¹ýµ°°×ÖÊ£¨Ã¸£©µÄ¹¦Äܼä½Ó¿ØÖÆÁËϸ°ûÄÚÈ«²¿ÓÐЧ³É·ÝµÄÉú²ú¡¢ÔËתºÍ¹¦ÄÜ·¢»Ó¡£Öü²ØÔÚÈκλùÒòÖеÄÉúÎïÐÅÏ¢¶¼±ØÐëÊ×Ïȱ»×ªÂ¼Éú³ÉRNA£¬²ÅÄܹ»µÃµ½±í´ï¡£DNAºÍRNAËäÈ»ºÜÏàËÆ£¬Ö»ÓÐT»òU¼°ºËÌǵĵڶþλ̼Ô×ÓÉÏÓÐËù²»Í¬£¬µ«ËüÃǵÄÉúÎïѧ»îÐÔÈ´ºÜ²»Í¬¡£ rMXN[,|v
RNAÖ÷ÒªÒÔµ¥Á´ÐÎʽ´æÔÚÓÚÉúÎïÌåÄÚ£¬Æä¸ß¼¶½á¹¹ºÜ¸´ÔÓ£»RNA¼Èµ£¸º×ÅÖü²Ø¼°×ªÒÆÒÅ´«ÐÅÏ¢µÄ¹¦ÄÜ£¬ÓÖÄÜ×÷ΪºËøֱ½ÓÔÚϸ°ûÄÚ·¢»Ó´úл¹¦ÄÜ¡£ ]I-Z]m"
7ByTnYe~S
µ°°×ÖÊÊÇÉúÎïÐÅϢͨ·ÉϵÄÖÕ²úÎһ¸ö»îϸ°ûÔÚÈκη¢Óý½×¶Î¶¼ÐèÒªÊýǧÖÖ²»Í¬µÄµ°°×ÖÊ¡£Òò´Ë£¬»îϸ°ûÄÚʱ¿Ì½øÐÐן÷ÖÖµ°°×Öʵĺϳɡ¢ÐÞÊΡ¢ÔËתºÍ½µ½â·´Ó¦¡£ I6~pV@h^=
@HT% n
Ò»¡¢ºËÜÕËáµÄºÏ³ÉÓë´úл sfLMkE
^<;V]cY`
ºËÜÕËáÊÇDNAºÍRNAµÄǰÌåÊÇϸ°ûÄÚ»¯Ñ§ÄÜÁ÷ͨÁìÓòÖеÄÔØÌ壨ATP£¬ GTP£©,ÊÇNAD¡¢FAD¡¢S-adenosylmethionine¼° Coenzyme AµÈµÄÖØÒª³É·Ý¡£ÔÚÌÇ´úлÖÐÒ²ÓÐÖØÒª×÷Óã¬ÈçÉú³ÉUDPGºÍ CDP-diacylglycerolµÈ¡£cAMP, cGMP»¹ÊǵڶþÐÅʹ¡£ )_a~}
U]=.
Cv
}Qwy
1¡¢De NovoàÑßʺËÜÕËáµÄÉúÎïºÏ³ÉʼÓÚPRPP £¨Phosphoribosyl 1-pyrophosphate£© W>!_|[a
$m7?3/YG
Õâһ;¾¶µÄµÚÒ»²½ÊÇÓɹȰ±õ£°·¾èÏ×Ò»¸ö°±»ùµ½PRPPµÄC-1λÉÏ£¬Éú³É5-phosphoribosylamine¡£ pa#d L!J
Æä´Î£¬°Ñ¸Ê°±ËáÖеÄÈý¸ö»ùÍżӵ½PRAÉÏ¡£ .id)VF-l
µÚÈý£¬ÓÉN10-¼×»ùËÄÇâÒ¶ËáÌṩһ¸ö¼×»ù¡£ +U_=*"@|
µÚËÄ£¬¹È°±õ£°·ÌṩÁíÒ»¸öN¡£ Ny_lrfh) [
µÚÎ壬ÍÑË®»·»¯ÐγÉßäßò»·¡£ 1[kMOp
µÚÁù£¬ôÈ»ù»¯ )q0. 0<f
µÚÆß£¬Í¨¹ý·Ö×ÓÖØÅŽ«ôÈ»ù´ÓßäßòµÚ4̼µÄ»·Íâ°±»ùÉÏ×ªÒÆµ½µÚ5λ̼Ô×ÓÉÏ¡£ CQwL|$)]Y
µÚ°Ë-¾Å£¬ÓÉÌìÃŶ¬õ£°·°ÑÁíÒ»¸ö°±»ù¼Óµ½µÚ5λ̼Ô×ÓÉÏ¡£ qe #P?[
µÚÊ®£¬ÔÙÓÉN10-¼×»ùËÄÇâÒ¶ËáÌṩһ¸ö¼×»ù¡£ .7zK@6i
µÚʮһ£¬ÍÑË®»·»¯£¬ÐγÉàÑßÊIMP¡£ A"`foI$0
"dsU>3u
²ÎÓëºÏ³ÉAMPµÄÊÇ¢ÙÏÙÜÕçúçêËáºÏ³ÉøºÍ¢ÚÏÙÜÕçúçêËáÁѽâø¡£ D*Ik7Pe
²ÎÓëºÏ³ÉGMPµÄÊÇ¢ÛIMPÍÑÇâøºÍ¢ÜXMP-¹È°±õ£°·õ£°·×ªÒÆÃ¸ ¡£ (* 1v\Q
tS|9fBdCs
2. àÑßʺËÜÕËáºÏ³ÉÖеķ´À¡µ÷½Ú ;WgJ<&33
3£®à×ऺËÜÕËáÊÇÓÉÌìÃŶ¬õ£°·¡¢ PRPPºÍ°±»ù¼×õ£Á×ËáµÈ¹²Í¬ÐÎ³ÉµÄ $k0kk
zR
`EU,
à×ऴÓÍ·ºÏ³É;¾¶²»Í¬ÓÚàÑßʵĺϳɣ¬6-Ô×Óà×ऻ·Ê×Ïȱ»ºÏ³É£¬È»ºó²ÅÓëºËÌÇ-5-Á×ËáÏàÁ¬¡£Õâ¸ö·´Ó¦ÐèÒª°±»ù¼×õ£Á×ËᣨCarbamoyl phosphate£©¡£ q ud\K+
4£®ºËÜÕµ¥Á×Ëáת»¯ÎªºËÜÕÈýÁ×Ëá _nD$b={g
·´Ó¦Éú³ÉµÄADP¿Éͨ¹ýÌǽͽâø»òÑõ»¯Á×Ëữ;¾¶±»½øÒ»²½Á×Ëữ¡£ {D!6%`HKV+
ATPÄܹ»°ÑÁ×Ëá»ùÍżӵ½ÆäËüËùÓкËÜÕµ¥Á×ËáÉÏÉú³ÉºËÜÕÈýÁ×Ëá¡£ o8zy^zN$6
ºËÜÕ¶þÁ×Ëá¿Éͨ¹ýÒ»¸ö¹«ÓõĺËÜÕ¶þÁ×Ëἤø±»½øÒ»²½Á×ËữÉú³ÉºËÜÕÈýÁ×Ëá¡£ Q9Uf.Lh2
5£®ºËÌǺËÜÕËᣨribonucleotides£©ÊÇÍÑÑõºËÌǺËÜÕËᣨDeoxyribonucleotides£©µÄǰÌå¡£ËùÓÐdNTP¶¼Ö±½ÓÀ´×ÔÓÚNTP£¨ÆäʵÊÇNDP£©¡£Õâ¸ö·´Ó¦ºÜÌØÊ⣬ÒòΪºËÌÇÉϵĻ¹Ô·´Ó¦·¢ÉúÓÚÒ»¸öûÓлµÄ̼Ô×ÓÉÏ¡£´ß»¯¸Ã·´Ó¦µÄøÊǺËÌǺËÜÕËỹÔø¡£ PGYXhwOI
´ó³¦¸Ë¾úºËÜÕËỹÔøÓÐÁ½´óÌØÕ÷£¬ËüµÄÉúÎïѧ»îÐԺ͵×ÎïÌØÒìÐÔͬʱÊÜЧӦ×Ó£¨effector molecules£©µÄÓ°Ï졣ÿ¸öR1ÑÇ»ùÉ϶¼ÓÐÁ½¸öµ÷½Úλµã£¬µ±Ó°ÏìÕûÌåø»îÐÔµÄÄǸöλµãÓëATPÏà½áºÏʱ£¬Ã¸»îÐÔÔö¼Ó£»¶øµ±ËüÓëdATP½áºÏʱ£¬Ã¸»îÐÔÏûʧ¡£ HODz*pI
µÚ¶þ¸öµ÷½Úλµã¿ØÖÆÁ˵×ÎïÌØÒìÐÔ¡£µ±dATPÓë¸ÃλµãÏà½áºÏʱ£¬UDPºÍCDPµÄ»¹Ô·´Ó¦ÓÅÏȽøÐС£µ±dTTPÓë¸ÃλµãÏà½áºÏʱ£¬GDPµÄ»¹Ô·´Ó¦ÓÅÏȽøÐС£ 0E?jW7yr
ºËÌǺËÜÕËỹԷ´Ó¦µÄÖ÷Òª¹ý³Ì *\(r+>*x*
1. »¹ÔøR2ÑÇ»ù´¦ÓÚÑõ»¯Ì¬-X¨B£¬ÏòºËÌÇ3¡¯Î»Ì¼Ô×ÓÉϵÄH·¢Æð¹¥»÷£¬Éú³É3¡¯Î»×ÔÓÉ»ù¡£ 6&DX] [G
2. R1ÑÇ»ùÉϵÄ-SH»ùÍÅΪ2¡¯-OHÌṩһ¸öHÔ×Ó£¬Ê¹Ö®Éú³É-OH2»ùÍÅ¡£ 4Y,R-+f
3. ÍÑË®ºó£¬3¡¯Î»×ÔÓÉ»ù°ïÖúά³Ö2¡¯Î»O+»ùÍÅ¡£ O$D'.t
4. R1ÑÇ»ùÉϵÄÁíÒ»¸ö-SH»ùÍÅΪ2¡¯-CH+Ìṩһ¸öHÔ×Ó n8uv#DsdK
5. 2¡¯ÉϵÄC¨B-OHÏòR2ÑÇ»ùÉϵÄX-H·¢Æð¹¥»÷¡£ a\IP12F?
6. 2¡¯ÉϵÄC-OHʧȥÑõÔ×Ó£¬Éú³ÉdNDP¡£ÆäÖУ¬dTMP£¨thymidylate£©À´×ÔÓÚdCDPºÍdUMP£¬ÆäÖ±½ÓǰÌåÊÇdUMP£¬ÓÉÐØÜÕËáºÏø£¨thymidylate synthase£©½«dUMPת»¯ÎªdTMP£»·´Ó¦Öеļ׻ùÀ´×ÔÓÚN5£¬N10-Methylene-tetrahydrofolate¡£ TlI<1/fP}
7¡¢àÑßʺÍà×ऽµ½âºó·Ö±ðÉú³ÉUric AcidºÍUrea¡£ .fN"@l
àÑßʺËÜÕËá½µ½â zrR`ecC(b
µÚÒ»²½ÊÇÔÚ5¡¯-ºËÜÕËáø£¨5¡¯-nucleotidase£©µÄ×÷ÓÃÏÂÏûÈ¥Á×Ëá»ùÍÅ£¬ÓÉAdenosine-monophosphate±ä³ÉAdenosine£¬»ò´ÓGMP±ä³ÉGuanosine¡£ t|9 GS|
¶þ¡¢ÔÚAdenosine deaminaseµÄ×÷ÓÃÏÂÉú³ÉInosine£» lZyG)0t,g
Èý¡¢ÔÚnucleosidaseµÄ×÷ÓÃÏÂÉú³ÉHypoxanthine»òÓÉGuanosineÉú³ÉGuanine£» .,7JAkB%t
ËÄ¡¢ÔÚXanthine oxidase»òGuanine deaminase×÷ÓÃÏÂÉú³ÉXanthine£» /CuXa%Ci^
Îå¡¢ÔÚXanthine oxidaseµÄ×÷ÓÃÏÂÉú³ÉUric acid¡£ SrFS#
àÑßÊ´úлͻ±ä»áÒýÆðÖØÒª¼²²¡¡£ AS E91T~
ÈçÈËÌåÄÚȱʧadenosine deaminase£¬»áÒý·¢ÑÏÖØµÄÃâÒßȱʧÐÔ¼²²¡£¬ÒòΪ´ËʱT-ÁܰͺÍB-ÁܰÍϸ°û²»ÄÜÕý³£·¢Óý¡£ADȱʧºó£¬Ï¸°ûÄÚdATPµÄº¬Á¿½«¸ß´ïÕý³£Ï¸°ûÖеÄ100±¶£¬¶ø¹ýÁ¿µÄdATPÔòÒÖÖÆÁËÆäÓàdNTPÔÚT-ÁܰÍϸ°ûÖеĺϳɡ£Ðí¶à»¯ÁÆ£¨chemotherapy£©Ò©¼Á¶¼Õë¶ÔºËÜÕËáºÏ³É;¾¶¡£ÈçAzaserineºÍAcivicin¶¼ÊÇGlutamineÀàËÆÎ±»ÓÃÓÚ×è¶ÏºËÜÕËáµÄÉúÎïºÏ³É¡£ }"|"Q7H
K`/`|1
ÐØÜպϳÉÖеÄÖ÷ÒªÒÖÖÆ¼ÁÓÐfluorouracil£¨·úë壩¡¢methotrexate£¨°±¼×»ùÒ¶ËᣩºÍaminopterin£¨°±à©ßÊ£©¡£·úëå±¾Éí²»ÊÇthymidylate synthase ÒÖÖÆ¼Á£¬µ«ËüÔÚϸ°ûÖб»×ª»¯ÎªFdUMPÒԺ󣬾ÍÄÜÖ±½ÓÓëTSÏà½áºÏ²¢Ê¹Ö®Ê§»î¡£°±¼×»ùÒ¶ËáºÍ°±à©ßʶ¼ÊÇdihydrofolate reductaseµÄÒÖÖÆ¼Á£¬°±¼×»ùÒ¶ËáÓë¸ÃøµÄÇ׺ÍÁ¦±Èµ×Îïdihydrofolate¸ß100±¶¡£ 7M<'ddAN
G2]4n T
¶þ¡¢°±»ùËá´úл GwG4LIp
°´ËùÕ¼µÄÖÊÁ¿±ÈÀý¼ÆË㣬NÔÚÉúÎïÌåÄÚµÄÖØÒªÐÔÅÅÔÚCHOÖ®ºó£¬ÁеÚ4λ¡£´óÁ¿NÔªËØ¶¼ÊÇÓлúµª£¬±»½áºÏÓÚ°±»ùËá»òºËÜÕËá·Ö×ÓÖС£ Ma'_e=+A
µØÇòÉϵֲ͝Îï¹²º¬µªÔ¼1.5¡Á1010t£¬¶øÃ¿Äêͨ¹ýÏõ»¯Ï¸¾úÒÔÆøÌ¬µªµÄÐÎʽÊͷŵ½´óÆøÖеĵª¾ÍÓÐ2¡Á108¡ª5¡Á108t¡£È«ÊÀ½çµª·Ê³§Ã¿ÄêÉú²úµÄ»¯·Ê½öº¬µªÔ¼108t£¬ËùÒÔ£¬Èç¹ûûÓÐÉúÎï¹Ìµª£¬ÉúÃüºÜ¿ì¾Í²»¸´´æÔÚÁË¡£ 2pzF5h
oq4}3bQ
1. ï§Í¨¹ý¹È°±Ëá¡ú¹È°±õ£°·±»½áºÏµ½ÓлúÎïÖÊÖС£ uch>AuF:
Ö÷ÒªÓÐÁ½²½·´Ó¦£º R)M_|ca
¢ÅGlutamate+ATP¡ú¦Ã-glutamylphosphate+ADP A a=u+
¢Æ¦Ã-Glutamyl phosphate+NH4+¡úglutamine+Pi+H+ t6,wjN-J
×ܽ᣺ yz-,)GB6
Glutamyl+NH4++ATP¡úglutamine+ ADP+Pi+H+ N[<H7_/3
Òò´Ë£¬¹È°±õ£°·ºÏ³ÉøÊǵª´úлÖеÄÖ÷Òªµ÷¿ØÎ»µã¡£ 4q'B<7{Q
Ôڴ󳦸˾úÖУ¬GSÓÉ12¸öÏàͬµÄÑÇ»ù£¨50kDa£©¾ÛºÏ¶ø³É£¬Æä»îÐÔ¼Èͨ¹ý¹¹Ïó±ä»¯£¬Ò²ÄÜͨ¹ý¹²¼ÛÐÞÊεķ½Ê½µÃµ½µ÷½Ú¡£Alanine£¬GlycineºÍÆäËüÖÁÉÙ6ÖÖgln´úл²úÎï¶¼ÊÇGS»îÐԵı乹ÒÖÖÆ¼Á£¬Ã¿¸öÒÖÖÆ¼Á¶¼Ö»Óв¿·ÖÒÖÖÆ×÷Óᣳý±ä¹¹ÒÖÖÆÖ®Í⣬GS»îÐÔ»¹Êܹ²¼ÛÐÞÊε÷½Ú¡£µ±µÚ397λÀÒ°±Ëá±»ÏÙÜÕ»¯ºó£¨¼ÓÉÏAMP£©£¬¸Ãø¸üÈÝÒ×Êܱ乹ÒÖÖÆ¼ÁµÄ·´À¡µ÷½Ú¡£ s:2|c]wQ#R
2.°±»ùËáµÄÉúÎïºÏ³É 'WI^nZM
¸ßµÈ¶¯Îï²»ÄܺϳɴóÔ¼Ò»°ë°±»ùËᣬֻÄÜ´ÓʳÎïÖÐÖ±½Ó»ñÈ¡ÕâЩ±ØÐè°±»ùËᣨEssential£©¡£ Yly@ww9t|
±í18-1 ÈËÌ屨Ðè°±»ùËá(*.²¸ÈéÆÚÖÁÓ×¶ùÆÚ±ØÐè) oEx\j+}@n
±í22-1 °±»ùËáºÏ³ÉµÄÁùÌõÖ÷Ҫ;¾¶ )J_\tv
3.°±»ùËáÍÑôÈ»ù»¯ºóÉú³ÉÓлú°·¡£Ðí¶àÖØÒªµÄÉñ¾µÝÖʶ¼Êǰ·»òÆä´ÎÉú´úл²úÎï¡£Tyrosine½µ½â²úÎïÓÐdopamine£¨¶à°Í°·£©£¬epinephrine£¨ÉöÉÏÏÙËØ£©£¬norepinephrine£¬Í³³ÆÎªCatecholamines£¨¶ù²è·Ó°·£©¡£ S@}1t4Ls:
4.¾«°±Ëá½µ½â²úÉúNO¨B(Nitric Oxide)¡£ (x"BR
±¾ÊÀ¼Í80Äê´ú£¬¿ÆÑ§¼Ò·¢ÏÖNOÊÇÈËÌåÄÚÖØÒªµÄÐźŷÖ×Ó£¬Ëü²ÎÓëÉñ¾´«µÝ¡¢ÄýѪºÍѪѹµ÷¿ØµÈһϵÁÐÉúÀí·´Ó¦¡£ËäÈ»ËüÊÇÆøÌ壬¼«Ò×À©É¢£¬µ«ÓÉÓÚËüÊ®·Ö»îÔ¾£¬ÆäÀ©É¢°ë¾¶Ò»°ãÖ»ÓÐ1mm¡£ ZxG}ViS4I
$`8Ar,Xz`
Èý¡¢°±»ùËá¼°¹¦Äܵ°°×ÖʺϳɺóµÄÐÞÊÎ ZT[3aXS
1.µ°°×Öʸոձ»ºÏ³Éʱ£¬¶¼ÒÔfMet£¨ÔºË£©»òMet£¨ÕæºË£©¿ªÊ¼£¬¶àëĺϳɺó£¬N¶ËµÄformyl group¡¢Met²Ð»ù£¬ÓÐʱ»¹°üÀ¨N´§¶à¸ö²Ð»ù»òC¶ËµÄ²Ð»ù¶¼»á±»Çгý¡£50%µÄÕæºËµ°°×ÖУ¬N-¶Ë²Ð»ùµÄ°±»ùËá»á±»N-ÒÒ»ù»¯¡£ [F_/2+e
2.ÇгýÐźÅëÄ¡£Ðí¶àµ°°×Öʶ¼´øÓÐ15-30¸ö²Ð»ùµÄsignal peptides£¬¸ºÔðÖ¸µ¼µ°°×ÖÊÔÚϸ°ûÖеľ«È·¶¨Î»¡£ c9\2YKo
3.ÌØ¶¨°±»ùËáµÄÐÞÊΡ£ RP2_l$
4.°±»ùËáµÄÌÇÜÕ»¯ SFb{o<0 =
5.°±»ùËáµÄÒìÎìÏ©»¯£¨Addition of Isoprenyl Groups£© +B'8|5tPX
6.ÓÐЩµ°°×ÖÊ»¹ÒªÓ븨»ù(prosthetic groups)Ïà½áºÏ£» 7_wJpTz
Cytochrome CÖ»ÓÐÓëѪºìËØ£¨heme£©Ïà½áºÏ²ÅÓй¦ÄÜ¡£´ËÍ⣬Acetyl-CoAôÈ»¯Ã¸³£ÓëBiotin·Ö×ÓÏà½áºÏ¡£ÓÐЩµ°°×ÖʱØÐë¾µ°°×øÇиîºó²ÅÓй¦ÄÜ¡£ÓÐЩµ°°×ÖÊÖ»ÓÐÔÚÐγɶþÁò¼üÖ®ºó²ÅÓй¦ÄÜ¡£ }m/RZP~=
Og2vGzD
ËÄ¡¢µ°°×ÖʵÄÔËÊäºÍ½µ½â cO\-
1¡¢¾ø´ó²¿·Ö±»ÔËÈëERÄÚÇ»µÄµ°°×Öʶ¼´øÓÐÒ»¸öSignal peptide¡£¸ÃÐòÁг£³£Î»ÓÚµ°°×Öʵݱ»ùÄ©¶Ë£¬³¤¶ÈÒ»°ãÔÚ13-36¸ö²Ð»ùÖ®¼ä£¬ÓÐÈý¸öÌØµã£º £¨1£©Ò»°ã´øÓÐ10-15¸öÊèË®°±»ùË᣻ £¨2£©³£³£ÔÚ¿¿½ü¸ÃÐòÁÐN-¶ËÊèË®°±»ùËáÇøÉÏÓδøÓÐ1¸ö»òÊý¸ö´øÕýµçºÉµÄ°±»ùË᣻ £¨3£©ÔÚÆäC-Ä©¶Ë¿¿½üµ°°×øÇиîλµã´¦³£³£´øÓÐÊý¸ö¼«ÐÔ°±»ùËᣬÀëÇиîλµã×î½üµÄÄǸö°±»ùËáÍùÍù´øÓк̵ܶIJàÁ´£¨Ala»òGly£©¡£ $s4Wkq
Ñо¿·¢ÏÖ£¬ÐźÅëİÑRibosomeÇ£Òýµ½ERÉÏ¡£µ°°×ÖʺϳÉÖ®³õ£¬Ò»µ©ÐźÅëÄÐòÁеÄN¶Ë±©Â¶ÔÚºËÌÇÌåÍ⣬¸ÃÐòÁУ¨°üÀ¨ºËÌÇÌ壩¾ÍѸËÙÓëSRP£¨signal recognition particle£©Ïà½áºÏ£¬ÓÕ·¢SRPÓëGTPÏà½áºÏ£¬Í£Ö¹ÐÂÉúëĵĽøÒ»²½ÑÓÉ죨´ËʱÐÂÉúëÄÒ»°ã³¤Ô¼70¸ö²Ð»ù×óÓÒ£©¡£ =(EI~N
ÊÜλÓÚERÍâĤÉϵÄSRP-receptor¼°ribosome-receptorµÄÇ£Òý£¬Õâ¸ö¸´ºÏÎï£*****TP-SRP-ribosome-mRNA-ÐÂÉúëÄ£©Á¢¼´ÏòERÍâĤ¿¿Â££¬²¢Í¨¹ýpeptide transport complex½øÈëERÄÚÇ»¡£ .}k(L4T|=
5.Rough ERÉϵĵ°°×Öʳ£³£Í¨¹ýÔË×ªÔØÌ彫¾¹ýÐÞÊεĵ°°×ÖÊËÍÈë¸ß¶û»ùÌ壬ÔÙ·Ö±ðË͵½¸÷¸öÑÇϸ°ûλµã¡£ 5tv<8~:K
6.µ°°×ÖÊÖеĺ˶¨Î»ÐòÁÐÒ»°ã²»±»Çгý¡£ - ZW3
µ°°×Öʵĺ˶¨Î»ÊÇͨ¹ý¶à¸öµ°°×µÄ¹²Í¬×÷ÓÃÀ´ÊµÏֵġ£Importin (¦Á,¦ÂÑÇ»ù)µÄ×÷ÓÃÓеãÏñSRPÊÜÌå¡£NLSµ°°×-Importin¸´ºÏÎïÍ£ÁôÔں˿×ÉÏ£¬²¢ÔÚRan-GTPaseµÄ×÷ÓÃÏÂͨ¹ýºË¿×¡£ T*I?9d{k
ϸ¾úϸ°ûÄÚÒ²´æÔÚÀàËÆµÄµ°°×ÖÊÔËתϵͳ¡£ ~gI{\iNF/
7¡¢µ°°×Öʽµ½âÊÇÒ»¸öÓÐÐòµÄ¹ý³Ì¡£ KECElK3uj
Ôڴ󳦸˾úÖУ¬Ðí¶àµ°°×ÖʵĽµ½âÊÇͨ¹ýÒ»¸öÒÀÀµÓÚATPµÄµ°°×ø£¨³ÆÎªLon£©À´ÊµÏֵġ£µ±Ï¸°ûÖдæÔÚÓдíÎó»ò°ëË¥ÆÚºÜ¶ÌµÄµ°°×ÖÊʱ£¬¸Ãµ°°×ø¾Í±»¼¤»î¡£Ã¿ÇгýÒ»¸öëļüÒªÏûºÄÁ½·Ö×ÓATP¡£ 'r} zY-FM`
ÔÚÕæºËÉúÎïÖУ¬µ°°×ÖʵĽµ½âÐèÒªUbiquitin£¬Ò»¸öÓÐ76¸ö°±»ùËá²Ð»ù×é³É¼«Îª±£Êصĵ°°×²ÎÓë¡£ÓëUbiquitinÏàÁ¬µÄµ°°×½«±»Ë͵½Ò»¸öÒÀÀµÓÚATPµÄµ°°×Öʽµ½âϵͳ£¨Proteasome£¬Mr. 1¡Á106£©¡£ |!H?+Jj:
³ÉÊì¶àëÄN-¶ËµÚÒ»¸ö²Ð»ù¶Ôµ°°×ÖʵÄÎȶ¨ÐÔÓÐÖØÒªÓ°Ïì ¡£ 4KI [D{
xMs]Hs
Îå¡¢DNA´úл a$9A(Pte
ÎÞÂÛÊÇÖ»º¬ÓÐÒ»¶ÔȾɫÌåµÄÔºËϸ°û»¹ÊÇ´øÓжà¶ÔȾɫÌåµÄÕæºËϸ°û£¬Ö»ÓÐÕû¸ö»ùÒò×éµÃµ½ÁËÍêÕû׼ȷµÄ¸´ÖÆ£¬Ï¸°û·ÖÁѲÅÄÜ˳Àû·¢Éú¡£ËùÒÔ˵£¬DNA¸´ÖÆµÄÆðʼ£¬±êÖ¾ÁËϸ°û½øÈëÒ»¸öеÄÖÜÆÚ¡£ =q(GHg;'
Ò»¡¢DNA¸´ÖÆ W~ULc9
¸ù¾Ý·´Ó¦½×¶ÎºÍËùÐèµÄ²»Í¬Ã¸À࣬DNAµÄ¸´Öƿɱ»·ÖΪÈý¸ö½×¶Î£¬¼´¸´ÖÆÆðʼ¡¢ÑÓÉìºÍÖÕÖ¹¡£Ã¿¸öDNA¸´ÖƵĶÀÁ¢µ¥Ôª±»³ÆÎª¸´ÖÆ×Ó£¨replicon£©£¬Ö÷Òª°üÀ¨¸´ÖÆÆðʼλµã£¨Origine of replication£©ºÍÖÕֹλµã£¨terminus£©¡£ÔºËÉúÎïµÄÕû¸öȾɫÌåÉÏÒ»°ãÖ»ÓÐÒ»¸ö¸´ÖÆÆðʼλµã¡£ )9=(|Lp
´ó³¦¸Ë¾úDNAµÄ¸´ÖÆÐèÒªÓÐ20ÖÖ×óÓ񵀿ºÍµ°°×ÖÊÒò×Ó²ÎÓ룬Õû¸öDNA¸´ÖÆ»úÆ÷±»³ÆÖ®ÎªDNA replicase system»òreplisome¡£ /}5B&TZ=(3
Helicase£¬ÈκÎDNAÔÚ±»¸´ÖÆÇ°¶¼±ØÐë½â¿ªË«Á´£¬Õâ¸ö¹ý³ÌÊÇÓÉhelicaseÀ´Íê³ÉµÄ£¬Ëü¿ÉÔÚATPµÄ×÷ÓÃϽ«DNAĸÁ´²»¶Ï½â¿ªÐγɵ¥Á´¡£ `C_'|d<HA
Topoisomerase£¬Ö÷Òª¹¦ÄÜÊÇÏû³ýDNA½âÁ´¹ý³ÌÖÐËù²úÉúµÄŤÇúÁ¦¡£ V%CUMH =U
DNA½áºÏµ°°×£¬Ê¹Ð½âÁ´µÄDNA±£³ÖÎȶ¨½á¹¹¡£ p|XAlia
Primases£¬ÎªDNA¸´ÖÆÌṩRNAÒýÎï¡£ ?Qqd "=k4
DNA polymerases£¬ºÏ³ÉÐÂÉúDNAÁ´£¬ÇгýRNAÒýÎï¡£
f+Dn9t
DNA Ligases£¬Ê¹ÐÂÉúDNAÁ´ÉϵÄȱ¿Ú£¨3¡¯-OH, 5¡¯-p£©Éú³ÉÁ×Ëá¶þõ¥¼ü¡£ XD-^w_
1. DNA¸´ÖÆµÄÆðʼ N;HIsOT}t
´ó³¦¸Ë¾úÖеĸ´ÖÆÆðʼλµãÊÇOri C£¬È«³¤245Bp£¬¸ÃÐòÁÐÔÚËùÓÐϸ¾ú¸´ÖÆÆðʼλµãÖж¼ÊDZ£Êصġ£ 6'OO-o
DNA¸´ÖÆÆðʼÖеÄÖ÷Òª²½Öè VjbG(nB?_
a. ´óÔ¼20¸ö×óÓÒµÄDnaAµ°°×Ê×ÏÈÓëOriCÖеÄ4¸ö9¼î»ùÖØ¸´ÇøÏà½áºÏ£» V/"}ku
b. ʶ±ð²¢Ê¹3¸ö13¼î»ù´®ÁªÖظ´ÇøDNAÐγɿª»·½á¹¹£» sI 4yG
c. DnaBµ°°×ÔÚDnaCµÄ°ïÖúÏÂÓëδ½âÁ´ÐòÁнáºÏ¡£Ã¿Áù¸öDnaBµ°°×ÐγÉÒ»×é²¢ÓëÒ»ÌõDNAĸÁ´½áºÏ£¬¿ÉÔÚ²»Í¬·½ÏòͬʱÆðʼDNAµÄ¸´ÖÆ¡£µ±Ï¸°ûÖдæÔÚ×ã¹»µÄSSBºÍDNA gyraseʱ£¬DnaBµÄ½âÁ´Ð§Âʷdz£¸ß¡£ 2L\3S ukj
Õû¸öDNA¸´Öƹý³ÌÖУ¬Ö»Óи´ÖÆÆðʼÊÜϸ°ûÖÜÆÚµÄÑϸñµ÷¿Ø¡£ noNm^hFL
"Once in each cell cycle¡£" */ OI*{Q
DNA¼×»ù»¯ÓëDNA¸´ÖÆÆðʼÃÜÇÐÏà¹Ø¡£OriCÖÐÓÐ11¸öGATC»ØÎĽṹ£¨Ò»°ã˵À´£¬256bp²ÅÓ¦ÓÐÒ»¸öGATCÖØ¸´£©¡£DNA×ÓÁ´±»ºÏ³Éºó£¬Ä¸Á´Á¢¼´±»¼×»ù»¯£¨³ÆÎªhemimethylated£©¡£´Ëʱ£¬oriCÓëϸ°ûÔÉúÖÊĤÏà½áºÏ¡£Ö»Óе±oriC±»´ÓĤÉÏÊͷųöÀ´£¬×ÓÁ´±»Dam¼×»ù»¯ºó£¬²ÅÄÜÓÐЧµØÓëDnaAµ°°×½áºÏ£¬ÆðʼÐÂÒ»ÂÖµÄDNA¸´ÖÆ¡£¸´ÖÆÆðʼ¿ÉÄÜ»¹ÊÜATPË®½â¹ý³Ìµ÷¿Ø£¬ÒòΪDnaAÖ»ÓÐÓëATPÏà½áºÏʱ²ÅÄÜÓëoriCÇøDNAÏà½áºÏ¡£ h3Fo-]0
2. DNA×ÓÁ´µÄÑÓÉì . p^xS6e{
Ö÷Òª°üÀ¨Á½¸ö²»Í¬µ«Ï໥ÓÐÁªÏµµÄʼþ£¬¼´Ç°µ¼Á´ºÍÖͺóÁ´µÄºÏ³É¡£ÓÉDNA helicase½â¿ªË«ÂÝÐý£¬ÓÉÍØÆÓÒ칹øÏû³ýDNAÁ´ÉϵÄŤÇúÁ¦£¬SSB½áºÏʹDNAµ¥Á´Îȶ¨¡£ ^[->
)
ǰµ¼Á´µÄºÏ³É£ºÓÉDnaG£¨primase£©ÔÚ¸´ÖÆÆðʼλµã¸½½üºÏ³ÉÒ»¸ö10-60 ntµÄRNAÒýÎȻºóÓÉpolII°ÑdNTP¼Óµ½¸ÃÒýÎïÉÏ¡£ mog9 jw
ÖͺóÁ´µÄºÏ³É£º²úÉúOkazaki fragments£¬Ïû³ýRNAÒýÎï²¢ÓÉDNA pol I²¹ÉÏÕâһС¶ÎDNAÐòÁУ¬ÓÉDNA Ligase°ÑÁ½¸öƬ¶ÎÏàÁ¬¡£ LxJ6M/".
3. DNAÁ´µÄÖÕÖ¹ EychR/s
µ±×ÓÁ´ÑÓÉì´ïµ½terminus region£¨ter£¬´øÓжà¸ö20bpÐòÁУ©Ê±£¬DNA¸´ÖƾÍÖÕÖ¹ÁË¡£TerÓеãÏñÒ»¸öÏݾ®£¨trap£©£¬Ê¹¸´ÖƲæÖ»ÄܽøÈ룬²»ÄܳöÀ´¡£TerµÄ¹¦ÄÜÖ÷ÒªÊÇÓÉTer-Tus¸´ºÏÎter utilization substance£©À´Íê³ÉµÄ¡£ *,#q'!Hq
4. ÕæºËϸ°ûDNAµÄ¸´ÖƱȴ󳦸˾ú¸ü¸´ÔÓ 9 Aivf+
ÕæºËÉúÎïµÄorigin of replication±»³ÆÎªARS-autonomously replicating sequences»òÕß±»³ÆÎªreplicators¡£Yeast replicators³¤Ô¼150dp£¬Óжà¸ö±£ÊØÖظ´Çø£¬¹²ÓÐÔ¼500¸öreplicators·Ö²¼ÓÚ½ÍĸµÄ17ÌõȾɫÌåÖС£ r(uP!n1+
,9ml>ji`=
¶þ¡¢DNAµÄËðÉËÐÞ¸´ E`p
'L!z
1£® ´íÅäÐÞ¸´£¨mismatch Repair£© 3n(*
E_n
´íÅäÐÞ¸´¶ÔDNA¸´ÖÆÖÒʵÐԵűÏ×Á¦´ï102-103£¬DNA×ÓÁ´ÖеĴíÅ伸ºõÍêÈ«¶¼±»ÐÞÕý£¬³ä·Ö·´Ó³ÁËĸÁ´µÄÖØÒªÐÔ¡£ ]b[,LwB\`~
2. ¼î»ùÇгýÐÞ¸´£¨Base-Excision Repair£© 85>S"%_
DNA gylcosylasesÄÜÌØÒìÐÔʶ±ð³£¼ûµÄDNAËðÉË£¨Èç°ûà×ऻòÏÙàÑßÊÈ¥°±õ£»¯²úÎ²¢½«ÊÜË𺦼î»ùÇгý¡£È¥µô¼î»ùºóµÄºËÜÕËá±»³ÆÎªAPλµã£¨apurinic or apyrimidinic£©¡£Ï¸°ûÖÐ×î³£¼ûµÄUracil Glycosylase¾ÍÄÜÌØÒìÐÔÇгýϸ°ûÖеÄÈ¥°±»ù°ûà×ड£ rFXSO=P?Z
3. ºËÜÕËáÇгýÐÞ¸´£¨nucleotide-excision repair£© W\ULUK
µ±DNAÁ´ÉÏÏàӦλÖõĺËÜÕËá·¢ÉúËðÉË£¬µ¼ÖÂË«Á´Ö®¼äÎÞ·¨ÐγÉÇâ¼ü£¬ÓɺËÜÕËáÇгýÐÞ¸´ÏµÍ³¸ºÔð½øÐÐÐÞ¸´¡£ R40W'N1%q
4.DNAµÄÖ±½ÓÐÞ¸´£¨Direct repair£© yMIT(
kEK[\f VE
Èý¡¢DNAµÄת×ù ~Q!~ eTw
DNAµÄת×ù£¬»ò³ÆÒÆÎ»£¨transposition£©£¬ÊÇÓÉ¿ÉÒÆÎ»Òò×Ó£¨transposable element£©½éµ¼µÄÒÅ´«ÎïÖÊÖØÅÅÏÖÏó¡£ÒѾ·¢ÏÖ"ת×ù"ÕâÒ»ÃüÃû²¢²»Ê®·Ö׼ȷ£¬ÒòΪÔÚת×ù¹ý³ÌÖУ¬¿ÉÒÆÎ»Òò×ÓµÄÒ»¸ö¿½±´³£³£ÁôÔÚÔÀ´Î»ÖÃÉÏ£¬ÔÚÐÂλµãÉϳöÏֵĽö½öÊÇ¿½±´¡£Òò´Ë£¬×ª×ùÓбðÓÚÍ¬Ô´ÖØ×飬ËüÒÀÀµÓÚDNAµÄ¸´ÖÆ¡£ ;?im(9h"v!
1£® ת×ù×ӵķÖÀàºÍ½á¹¹ÌØÕ÷ 'yT`ef
a. ¼òµ¥×ª×ù×Ó {'(ej5,6
ת×ù×Ó£¨transposon£¬Tn£©ÊÇ´æÔÚÓÚȾɫÌåDNAÉÏ¿É×ÔÖ÷¸´ÖƺÍÒÆÎ»µÄ»ù±¾µ¥Î»¡£ :Kay$r0+
×î¼òµ¥µÄת×ù×Ó²»º¬ÓÐÈκÎËÞÖ÷»ùÒò¶ø³£±»³ÆÎª²åÈëÐòÁУ¨insertion sequence£¬IS£©£¬ËüÃÇÊÇϸ¾úȾɫÌå»òÖÊÁ£DNAµÄÕý³£×é³É²¿·Ö¡£Ò»¸öϸ¾úϸ°û³£´øÓÐÉÙÓÚ10¸öISÐòÁС£×ª×ù×Ó³£³£±»¶¨Î»µ½Ìض¨µÄ»ùÒòÖУ¬Ôì³É¸Ã»ùÒòÍ»±ä¡£ISÐòÁж¼ÊÇ¿ÉÒÔ¶ÀÁ¢´æÔڵĵ¥Ôª£¬´øÓн鵼×ÔÉíÒÆ¶¯µÄµ°°×¡£ u
2lXd'
b.¸´ºÏʽת×ù×Ó£¨composite transposon£©ÊÇÒ»Àà´øÓÐijЩ¿¹Ò©ÐÔ»ùÒò£¨»òÆäËûËÞÖ÷»ùÒò£©µÄת×ù×Ó£¬ÆäÁ½ÒíÍùÍùÊÇÁ½¸öÏàͬ»ò¸ß¶ÈͬԴµÄISÐòÁУ¬±íÃ÷ISÐòÁвåÈ뵽ij¸ö¹¦ÄÜ»ùÒòÁ½¶Ëʱ¾Í¿ÉÄܲúÉú¸´ºÏת×ù×Ó¡£Ò»µ©Ðγɸ´ºÏת×ù×Ó£¬ISÐòÁоͲ»ÄÜÔÙµ¥¶ÀÒÆ¶¯£¬ÒòΪËüÃǵŦÄܱ»ÐÞÊÎÁË£¬Ö»ÄÜ×÷Ϊ¸´ºÏÌåÒÆ¶¯¡£ |[wyc!nY).
2¡¢×ª×ù×÷ÓõĻúÖÆ 5!:._TcO
ת×ùʱ·¢ÉúµÄ²åÈë×÷ÓÃÓÐÒ»¸öÆÕ±éµÄÌØÕ÷£¬ÄǾÍÊÇÊÜÌå·Ö×ÓÖÐÓÐÒ»¶ÎºÜ¶ÌµÄ£¨3-12bp£©¡¢±»³ÆÎª°ÐÐòÁеÄDNA»á±»¸´ÖÆ£¬Ê¹²åÈëµÄת×ù×ÓλÓÚÁ½¸öÖØ¸´µÄ°ÐÐòÁÐÖ®¼ä¡£²»Í¬×ª×ù×ӵİÐÐòÁг¤¶È²»Í¬£¬µ«¶ÔÓÚÒ»¸öÌØ¶¨µÄת×ù×ÓÀ´Ëµ£¬ËüËù¸´ÖƵİÐÐòÁг¤¶È¶¼ÊÇÒ»ÑùµÄ£¬ÈçIS1Á½Òí×ÜÓÐ9¸ö¼î»ù¶ÔµÄ°ÐÐòÁУ¬¶øTn3Á½¶Ë×ÜÓÐ5bpµÄ°ÐÐòÁС£ my[,w$YM
ת×ù¿É±»·ÖΪ¸´ÖÆÐԺͷǸ´ÖÆÐÔÁ½´óÀà¡£ÔÚ¸´ÖÆÐÔת×ùÖУ¬ËùÒÆ¶¯ºÍתλµÄÊÇÔת×ù×ӵĿ½±´¡£×ª×ùø£¨transposase£©ºÍ½âÀëø£¨resolvase£©·Ö±ð×÷ÓÃÓÚÔʼת×ù×Ӻ͸´ÖÆ×ª×ù×Ó¡£TnAÀàת×ùÖ÷ÒªÊÇÕâÖÖÐÎʽ¡£ÔڷǸ´ÖÆÐÔת×ùÖУ¬Ôʼת×ù×Ó×÷Ϊһ¸ö¿ÉÒÆ¶¯µÄʵÌåÖ±½Ó±»ÒÆÎ»£¬ISÐòÁС¢Mu¼°Tn5µÈ¶¼ÒÔÕâÖÖ·½Ê½½øÐÐת×ù¡£ G^"H*a
3.ת×ù×÷ÓõÄÒÅ´«Ñ§Ð§Ó¦ S1C^+Sla]
¢Ù ת×ùÒýÆð²åÈëÍ»±ä;¢Ú ת×ù²úÉúеĻùÒò;¢Û ת×ù²úÉúµÄȾɫÌå»û±ä;¢Ü ת×ùÒýÆðµÄÉúÎï½ø»¯. OPJgIU%
Dh8(HiXf:
Áù¡¢RNA´úл CveWl$T12
³ýÁËijЩRNA²¡¶¾Ö®Í⣬ËùÓÐRNA·Ö×Ó¶¼À´×ÔÓÚDNA¡£»ùÒò×éDNAͨ¹ýÒ»¸ö±»³ÆÎª×ªÂ¼µÄ¹ý³Ì°ÑÖü´æÔÚË«Á´DNA·Ö×ÓÖеÄÒÅ´«ÐÅϢת»»µ½ÓëÄ£°åDNAÁ´Ï໥²¹µÄRNAµ¥Á´ÉÏ¡£ -RCv7U`
mRNA£¬±àÂëÁËÒ»¸ö»ò¶à¸öµ°°×ÖÊÐòÁУ»tRNA£¬°ÑmRNAÉϵÄÒÅ´«ÐÅÏ¢±äΪ¶àëÄÖеݱ»ùËáÐÅÏ¢£»rRNA£¬ÊǺϳɵ°°×ÖʵŤ³§ºËÌÇÌåÖеÄÖ÷Òª³É·Ý¡£ x[}06k'
1£® ÒÀÀµÓÚDNAµÄRNAºÏ³É *K!7R2Rat
´ÓDNAºÏ³É·´Ó¦µÄ»¯Ñ§±¾ÖÊ¡¢¼«ÐÔºÍÄ£°åµÄʹÓÃÕâÈý·½ÃæÀ´Ëµ£¬×ªÂ¼Óë¸´ÖÆÊÇÏàͬµÄ¡£µ«ÊÇ£¬Ò²´æÔÚÈý¸öÖ÷Òª²»Í¬µã£º Q2R-z^pd
A£® ת¼Öв»ÐèÒªRNAÒýÎ ris;Iu^v0
B£®×ªÂ¼·´Ó¦Ò»°ãÖ»ÓÃһС¶ÎDNA×öÄ£°å£» NV(fN-L
C£®ÔÚ×ªÂ¼Çø£¬Ò»°ã¶¼Ö»ÓÐÒ»ÌõDNAÁ´¿ÉÒÔ×÷Ϊģ°å¡£ b60[({A\s&
2.RNAºÏ³ÉµÄÖÕÖ¹ RR'(9QJ$
Ò»µ©RNA¾ÛºÏøÆô¶¯ÁË»ùÒòת¼£¬Ëü¾Í»áÑØ×ÅÄ£°å5¡¯¡ú3¡¯·½Ïò²»Í£µØÒƶ¯£¬ºÏ³ÉRNAÁ´£¬Ö±µ½Óöµ½ÖÕÖ¹ÐźÅʱ²ÅÊÍ·ÅÐÂÉúµÄRNAÁ´£¬²¢ÓëÄ£°åDNAÍÑÀë¡£ )ys=+Pz
Ñо¿RNAÁ´ÖÕֹʱÓöµ½×î³£¼ûµÄÎÊÌâÊÇ3¡¯¶ËºËÜÕËáµÄ¶¨Î»£¬ÒòΪ»îϸ°ûÄÚ²¿¸ù¾ÝÖÕÖ¹ÐźÅÕýÈ·ÖÕÖ¹µÄRNAÓëÒ»¸ö¾¹ý¼ô½ÓµÄRNAÔÚ3¡¯¶ËûÓÐÁ½Ñù£¬¶¼ÊÇ-OH»ùÍÅ¡£Ä£°åDNAÉ϶¼ÓÐÖÕֹת¼µÄÌØÊâÐźÅ--ÖÕÖ¹×Ó£¬Ã¿¸ö»ùÒò»ò²Ù×Ý×Ó¶¼ÓÐÒ»¸öÆô¶¯×Ó£¬Ò»¸öÖÕÖ¹×Ó¡£ÔÚÐÂÉúRNAÖгöÏÖ·¢¿¨Ê½½á¹¹»áµ¼ÖÂRNA¾ÛºÏøµÄÔÝÍ££¬ÆÆ»µRNA-DNAÔÓºÏÁ´5¡¯¶ËµÄÕý³£½á¹¹¡£¹Ñ¾ÛUµÄ´æÔÚʹÔÓºÏÁ´µÄ3¡¯¶Ë²¿·Ö³öÏÖ²»Îȶ¨µÄrU£®dAÇøÓò¡£ )j(fWshP
a. ÒÀÀµÓÚ¦ÑÒò×ÓµÄÖÕÖ¹ F42TKPN^uu
¦ÑÒò×ÓÊÇÒ»¸öÏà¶Ô·Ö×ÓÖÊÁ¿Îª2.0¡Á105µÄÁù¾ÛÌåµ°°×£¬ËüÄÜË®½â¸÷ÖÖºËÜÕÈýÁ×Ëᣬʵ¼ÊÉÏÊÇÒ»ÖÖNTPø¡£ÓÉÓÚ´ß»¯ÁËNTPµÄË®½â£¬¦ÑÒò×ÓÄÜ´ÙʹÐÂÉúµÄRNAÁ´´ÓÈýԪת¼¸´ºÏÎïÖнâÀë³öÀ´£¬´Ó¶øÖÕֹת¼¡£ ?bn;{c;E
ÓÐÈËÈÏΪ£¬ÔÚRNAºÏ³ÉÆðʼÒԺ󣬦ÑÒò×Ó¼´¸½×ÅÔÚÐÂÉúµÄRNAÁ´ÉÏ£¬¿¿ATPË®½â²úÉúµÄÄÜÁ¿£¬ÑØ×Å5¡¯¡ú3¡¯·½Ïò³¯RNA¾ÛºÏÃ¸ÒÆ¶¯£¬µ½´ïRNAµÄ3¡¯-OH¶ËºóÈ¡´úÁËÔÝÍ£ÔÚÖÕֹλµãÉϵÄRNA¾ÛºÏø£¬²¢´ÓÄ£°åºÍøÉÏÊÍ·ÅRNA£¬Íê³Éת¼¹ý³Ì¡£ÖÕÖ¹¹ý³ÌÐèÒªÏûºÄÄÜÁ¿£¬ËùÒÔ£¬¦ÑÒò×Ó¾ßÓÐÖÕֹת¼ºÍºËÜÕÈýÁ×ËáøÁ½ÖÖ¹¦ÄÜ¡£ )MMhlcNC
b¡¢²»ÒÀÀµÓÚ¦Ñ Òò×ÓµÄÖÕÖ¹ y 2cL2c$BT
ÈôÖÕÖ¹µãÉÏÓδæÔÚÒ»¸ö¸»º¬GC¼î»ùµÄ¶þÖØ¶Ô³ÆÇø£¬ÓÉÕâ¶ÎDNAת¼²úÉúµÄRNAÈÝÒ×Ðγɷ¢¿¨Ê½½á¹¹£»ÔÚÖÕÖ¹µãÇ°ÃæÓÐÒ»¶ÎÓÉ4-8¸öA×é³ÉµÄÐòÁУ¬µ¼ÖÂת¼²úÎïµÄ3¡®¶ËΪ¹Ñ¾ÛU¡£ÕâÁ½ÖÖ½á¹¹ÌØÕ÷µÄ´æÔÚͬÑù¾ö¶¨ÁËת¼µÄÖÕÖ¹¡£ a5>)?m
ÔÚÐÂÉúRNAÖгöÏÖ·¢¿¨Ê½½á¹¹»áµ¼ÖÂRNA¾ÛºÏøµÄÔÝÍ££¬ÆÆ»µRNA-DNAÔÓºÏÁ´5¡¯¶ËµÄÕý³£½á¹¹¡£¹Ñ¾ÛUµÄ´æÔÚʹÔÓºÏÁ´µÄ3¡¯¶Ë²¿·Ö³öÏÖ²»Îȶ¨µÄrU£®dAÇøÓò¡£ ;4R
=eI
3.RNA¾ÛºÏøII¼°×ªÂ¼Òò×ÓÔÚÆô¶¯×ÓÉϵÄ×°Åä mC%%)F'Zf
TF¢òH»¹²ÎÓëDNAµÄËðÉËÐÞ¸´¡£µ±RNA pol¢òת¼¹ý³ÌÖÐÅöµ½ÊÜËðÉ˵ĺËÜÕËáʱ£¬TF¢òHÄܼ°Ê±Æô¶¯ºËÜÕËáÇгýÐÞ¸´ÏµÍ³£¬½«ËðÉËÐÞ¸´¡£ e%'z=%(
Actinomycin DºÍAcridine×è¶ÏRNAÁ´µÄÑÓÉì #?A]v>I;C
4.RNAµÄ¼Ó¹¤³ÉÊì #%:`p9p.S
ËùÒÔ£¬RNA¼Ó¹¤³ÉÊìÖ÷Òª°üÀ¨£º5¡¯¼Óñ×ӽṹ£»3¡¯¼Ó¶à¾ÛA£»ÇгýÄÚº¬×Ó ¡£ d~vTD|
Et
ÔÚGroup IÄÚº¬×ÓÇгýÌåϵÖУ¬ÄñÜÕ»òÄñÜÕËáµÄ3¡¯-OH ×÷ΪÇ׺˻ùÍÅÏòIntron 5¡¯µÄÁ×Ëá¶þõ¥¼ü·¢Æð½ø¹¥¡£ d
"LoK,p#
Group IIÄÚº¬×ÓÇгýÌåϵ fuQ4rt[i
ºËÄÚmRNAÔʼת¼²úÎïµÄ¼ô¼·½Ê½¿ÉÄÜÊÇ×î³£¼ûµÄ¡£ÔÚÕâһģʽÖУ¬RNAµÄ¼ô¼ÐèÒªÌØÒìÐÔRNA-protein-¸´ºÏÎïsmall nuclear rebonucleoproteins£¨snRNP£©ºÍsmall nuclear RNAs£¨snRNAs£©¡£ÒѾ·¢ÏÖÖÁÉÙÓÐ5ÖÖsnRNAs--U1£¬U2£¬U4£¬U5£¬U6¡£